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ABSTRACT 




γ-Secretase is an enzymatic complex critical to amyloid formation and other important 
pathophysiological processes. Non-specific γ-secretase inhibitors are not ideal for 
intervention of familial Alzheimer’s disease. The four essential include Presenilin (PS1 or 
PS-2), APH-1, Pen-2, nicastrin (Nct). Also γ-secretase cleaves a variety of substrates 
(over 30). But different sites are cleaved even in a single substrate and no consensus 
sequence for cleavage by γ-secretase is identified. We hypothesize that consensus 
compositional sequence (or functional domain) in components of γ-secretase and/or its 
substrates should exist during γ-secretase regulation and specific γ-secretase inhibitor 
based on such consensus sequence (or functional domain) may act as a therapeutic 
intervention for familial Alzheimer’s disease. We divide our research into two stages. At 
Stage I, we find the candidates by the methods of bioinformatics. The less, the better. By 
using the resources of genetic and protein databases and tools, selecting software to apply 
sequence analysis, modeling and simulation, and pattern recognition of γ-secretase 
regulation, we identify candidates of consensus sequences (or functional domains). At 
Stage II, we use the traditional biological methods to verify the critical role of the 
candidates including the protein purification, recognition, and functional domain 




















I would like to take this great opportunity to thank my supervisor, Dr. Bing-Hua Jiang, 
for his endless and selfless support, guidance, insights and advice in the hard times, 
giving me constant encouragement. I would like to express my most profound gratitude 
to my co-advisor, Dr. Donald Adjeroh, for his greatness, scientific insights, inspiration 
and patience to keep me on the right track. I would like to thank Dr. Jia Luo for his time 
and constructive criticism in my thesis, which has helped develop my critical thinking. I 
would like to thank Dr. Xiaobo Zhou for his help and advice on experimental data as well 
as with presentation of my data. I would like to thank David Woo and Thomas Wessel for 
their open mind suggestion and discussion, which makes everyday an enjoyable day. I 









1. Introduction..................................................................................................................... 1 
1.1 Alzheimer’s Disease and Amyloid-β ........................................................................ 1 
1.2 Secretase ................................................................................................................... 3 
1.3 Contributions ............................................................................................................ 5 
1.4 Organization.............................................................................................................. 6 
2. Literature Review............................................................................................................ 7 
2.1 Alzheimer’s Disease hypothetic mechanisms........................................................... 7 
2.2 γ-Secretase ................................................................................................................ 9 
2.2.1 Presenilin.......................................................................................................... 10 
2.2.2 Nicastrin........................................................................................................... 12 
2.2.3 APH-1 .............................................................................................................. 13 
2.2.4 PEN-2............................................................................................................... 14 
2.3 Notch....................................................................................................................... 15 
2.3.1 Mechanism....................................................................................................... 15 
2.3.2 Function ........................................................................................................... 16 
2.3.3 Notch Cascade ................................................................................................. 16 
2.4 A Bioinformatic Solution........................................................................................ 17 
2.5 Redundancy and Immunology ................................................................................ 18 
3. Methodology ................................................................................................................. 20 
3.1 Overview................................................................................................................. 20 
3.2 Methods .................................................................................................................. 21 
3.2 The Problem and Main Contribution ...................................................................... 23 
3.3 Motif Determination ............................................................................................... 24 
3.3.1 Overview.......................................................................................................... 25 
3.3.2 Motif Selection................................................................................................. 25 
3.4 Motif Determination with Mutation ....................................................................... 26 
3.5 Conclusion .............................................................................................................. 28 
4. Motifs of γ-Secretase and Its Substrates ....................................................................... 29 
5. Discussion and Conclusion ........................................................................................... 42 




Aß: Amyloid Beta 
Aß40: Amyloid Beta 40 
Aß42: Amyloid Beta 42 
Aτ: Amyloid-τ 
ACANA: Accurate Anchoring Alignment 
ACH: Acethylcholine 
ANOVA: One Way Analysis of Variance 
APH-1: Anterior Pharynx-defective 1 
APH-1a: Anterior Pharynx-defective 1 Homolog A (C. Elegans)  
APH-1b: Anterior Pharynx-defective 1 Homolog B (C. Elegans) 
APLP2: Amyloid Beta (A4) Precursor-Like Protein 2 
APP: Amyloid Precursor Protein 
BACE: ß-Secretase 
BLAST: Basic Local Alignment Search Tool 
BLOSUM: Blocks of Amino Acid Substitution Matrix 
DNA: Deoxyribonucleic Acid 
ELISA: Enzyme Linked Immunosorbent Assay 
FAD: Familial Alzheimer’s Disease 
GAPDH: Dehydrogenase 
GLUT1: Glucose Transporter 1 
H2O: Water 
IgE: Immunoglobulin E 
IgG: Immunoglobulin G 
IL-: Interleukin 
MEM: Maximal Exact Matches 
MUM: Maximum Unique Match 
MUSCLE: Multiple Sequence Comparison by Log-Expectation 
NCT: Nicastrin 
NK: Natural Killer 
 vi
NOR1: Neuron-Derived Orphan Receptor 1 
NSAID: Non-Steroidal Anti-Inflammatory Drugs 
NUR77: Nerve Growth Factor IB 
P3: Proximal Third 
PAM: Point Accepted Mutation 
PCA: Passive Cutaneous Assay 
Pen-2: Presenilin Enhancer 2 
PS1: Presenilin 1 (Particular on Human) 
PS2: Presenilin 2 (Particular on Human) 
PSen1: Presenilin 1 
PSen2: Presenilin 2 
RNA: Ribonucleic Acid 
SCP: Sorted Common Prefix 
T-COFFEE: Tree-Based Consistency Objective Function For Alignment Evaluation 
TGF-β: Tumor Necrosis Factor Beta 
Th1: T Helper 1 
Th2: T Helper 2 
TNF: Tumor Necrosis Factor 
UV: Ultraviolet 
VH: Vehicle 
γ-Secretase: Gamma Secretase 
α-secretase: Alpha Secretase 






1.1 Alzheimer’s Disease and Amyloid-β 
 
Alzheimer's disease is a neurodegenerative disease that, in its most common form, is 
found in people over age 65. Approximately 24 million people worldwide have dementia 




Figure 1. Histopathologic image of senile plaques seen in the cerebral 




Plaques which contain misfolded peptides called amyloid-β (Aβ) are formed in the brain 
many years before the onset of Alzheimer's disease. Together, these plaques and 
neurofibrillary tangles form the pathological signs of the disease. These features can only 
be discovered at autopsy and help to confirm the clinical diagnosis. Medications can help 
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relieve the symptoms of the disease, but evidence proves that they canot change the 
course of the underlying pathology. 
 
Experimental and genetic evidence has indicated that amyloid-β (Aβ) plays an essential 
role in the Alzheimer’s disease pathogenesis. The malicious protein aggregates in the 
brain hippocampus and brain cortex of the patients of Alzheimer’s disease as well as self-
accumulation to form malicious oligomers which will cause neurodegeneration. Genetic 
defects identified include mutations in the Presenlin 1 gene on chromosome 14, the 
Presenilin 2 gene on chromosome 1, and the amyloid precursor protein (APP) gene on 
chromosome 21.  
 
Alzheimer's disease has been identified as a protein misfolding disease due to the 
accumulation of abnormally folded amyloid-β (Aβ) in the brains of Alzheimer's disease 
patients (Hashimoto et al 2003). Amyloid-β (Aβ) is a short peptide that is a proteolytic 
byproduct of the transmembrane protein amyloid precursor protein (APP), whose 
function is unclear but thought to be involved in neuronal development (Rudolph et al 
2000). Although Amyloid-β (Aβ) monomers are soluble and harmless, they undergo a 
dramatic conformational change at sufficiently high concentration to form a beta sheet-
rich tertiary structure that aggregates to form amyloid fibrils (Ohnishi et al 2004) that 
deposit outside neurons in dense formations known as senile plaques or neuritic plaques, 
in less dense aggregates as diffuse plaques, and sometimes in the walls of small blood 
vessels in the brain in a process called amyloid angiopathy or congophilic angiopathy. 
 
Recent research includes hypotheses centered on the effects of the misfolded and 
aggregated proteins, amyloid-β (Aβ) and amyloid-τ (Aτ). The τ hypothesis is supported 
by the long-standing observation that deposition of amyloid plaques do not correlate well 
with neuron loss (Mudher et al 2002). However, a majority of researchers support the 




Secretases are enzymes that cut pieces off a longer protein that is embedded in the cell 
membrane. There are three types of components for secretase, namely α-secretase, β-
secretase and γ-secretase.  
 
 
Figure 2. Amyloid-β is created from amyloid precursor protein, through 
two sequential proteolytic cleavages where secretases act on the amyloid 
precursor protein (APP) to cleave the protein into three fragments. 
Sequential cleavage by β-secretase (BACE) and γ-secretase produces the 
amyloid-β (Aβ) peptide fragment that aggregates into plaques in the brains 
of Alzheimer's disease patients. 
 
 
Amyloid-β is heterogenous and formed from the precursor protein, called amyloid 
precursor protein, through two sequential proteolytic cleavages that involve β-secretase 
and γ-secretase. Specifically speaking, secretases act on the amyloid precursor protein 
(APP) to cleave the protein into three fragments. Sequential cleavage by β-secretase 
(BACE) and γ-secretase produces the amyloid-β (Aβ) peptide fragment that aggregates 
into clumps called "plaques" in the brains of Alzheimer's disease patients. If α-secretase 
acts on amyloid precursor protein (APP) first instead of β-secretase (BACE), no amyloid-
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β (Aβ) is formed because α-secretase recognizes a target protein sequence closer to the 
cell surface than β-secretase (BACE). The non-pathogenic middle fragment formed by an 
α-secretase and γ-secretase cleavage sequence is referred to as P3. 
 
However, together with β-secretase, γ-secretase will cleave the amyloid precursor protein 
by creating peptides of various lengths, namely Aβ40 and Aβ42. The longer one of Aβ40 
and Aβ42 is more aggregating than the other one. The ratio of Aβ42 over Aβ40 is 
increased by familial Alzheimer’s disease mutations occurring in the presenilin genes or 
in amyloid precursor protein, near the γ-secretase cleavage site. Thus, γ-secretase is able 
to determine the solubility of the created Aβ fragment and attract a wide popular attention 
in pharmaceutical drug industry. 
 
The structure of the three secretases varies widely. The α-secretase gene has not been 
conclusively identified but is believed to be a metalloproteinase. β-secretase (BACE) is a 
transmembrane protein with an extracellular aspartic acid protease domain.  
 
γ-secretase is an integral membrane protein, that cleaves single-pass transmembrane 
proteins at residues within the transmembrane domain. It is a protein complex containing 
presenilin, nicastrin, ACH-1, and PEN-2 and its biological mechanism remains under 
extensive research interests. Presenilin is believed to harbor the protease domain and 
represents an important example of a rare type of protease that cleaves targets within the 
cell membrane. 
 
Several successful γ-secretase inhibitors have been discovered by screening drug libraries 
and designing aspartyl protease transition-state analogues based on the amyloid precursor 
protein (APP) substrate cleavage site. Most of these compounds are very general, not 
specific enough for γ-secretase cleavage site of amyloid precursor protein (APP), and 
equally inhibit the processing of other γ-secretase substrates, such as Notch and other 
cell-surface proteins and receptors involved in embryonic development, haematopoiesis, 
cell adhesion and cell/cell contacts. 
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Thus, it’s more desirable for research scientists to focus on finding compounds that show 
selectivity for amyloid precursor protein (APP) cleavage and particularly inhibit the 
formation of the aggregating form of Aβ42. Compounds that target the substrate docking 
site instead of the enzyme active site could be another featured point worth of 
investigation as an alternative strategy. The finding that some NSAID analogues 
preferentially inhibit the formation of Aβ42 over Aβ40 and do not affect Notch 
processing has opened a new therapeutic window. The progress in design of selective 
inhibitors as well as recent results obtained in animal studies prove that γ-secretase 
remains among the best targets for the therapeutic control of amyloid build-up in 
Alzheimer’s disease. The full understanding of γ-secretase regulation may yet uncover 
new therapeutic interests.  
 
Besides the involvement in the pathogenesis of Alzheimer's disease, these proteins also 
have other functional roles in the cell. γ-secretase plays an essential role in developmental 
signalling by the transmembrane receptor Notch, freeing the cytoplasmic tail of Notch to 
travel to the cell nucleus to act as a transcription factor. Although β-secretase (BACE) 
cleaves the extracellular domains of several transmembrane proteins, its physiological 
function remains unknown. 
 
1.3 Contributions 
Many biochemists and biological scientists have tried to narrow down a way to determine 
the γ-secretase cleavage site mechanisms based on their primary, secondary, tertiary and 
quaternary structures. In this thesis, we are able to determine the consensus compositional 
sequences or functional domain of γ-secretase and its substrates as a possible therapeutic 
intervention. Then, we find the candidates of consensus sequence and functional domain 
by the methods of bioinformatics and collaborate to use traditional biological methods to 
verify the critical role of candidates including protein purification, recognition and 
domain functional interaction.  
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We also hope that we can apply the sequence comparison techniques and identify the 
candidate motifs and domains for all components of γ-secretase and its substrates. 
Meanwhile, we plan to biologically knockout and verify the functionality of those 
identified motifs and domains including protein purification, recognition and interaction. 
Finally we evaluate the efficacy of the bioinformatics tools and cast the direction of 
prospective improvements. 
1.4 Organization 
The thesis is organized as follows; Chapter 1 gives an overall introduction. Chapter 2 
reviews the literature and related work. We present the typical genetic structures. Then, 
we go over the current methods in γ-secretase identification. Then, we describe the 
relation among amyloid-β (Aβ) and γ-secretase. Chapter 3 presents our primary 
methodology. We describe the bioinformatics approach to obtain the motifs and domains 
for amyloid-β (Aβ) and γ-secretase. We give evidence for the idenfitication. Chapter 4 
presents the results of the application of our methodology. We conclude the thesis with a 

















2. Literature Review 
 
2.1 Alzheimer’s Disease hypothetic mechanisms 
 
There are three major competing hypotheses on the possible cause of the Alzheimer’s 
disease. The oldest, on which most currently available drug therapies are based, is known 
as the "cholinergic hypothesis" and suggests that Alzheimer’s disease is due to reduced 
biosynthesis of the neurotransmitter acetylcholine. The medications that treat 
acetylcholine deficiency have served to only treat symptoms of the disease and have 
neither halted nor reversed it (Walker et al 2006). The cholinergic hypothesis has not 
maintained widespread support in the face of this evidence, although cholingeric effects 
have been proposed to initiate large-scale aggregation (Shen 2004) leading to generalized 
neuroinflammation (WenK 2006).  
 
Recent research includes hypotheses centered on the effects of the misfolded and 
aggregated proteins, amyloid-β and amyloid-τ. The two positions differ, with one stating 
that the amyloid-τ protein abnormalities initiate the disease cascade, while the other states 
that amyloid-β (Aβ) deposits are the causative factor in the disease (Mudher et al 2002). 
The amyloid-τ hypothesis is supported by the long-standing observation that deposition 
of amyloid plaques do not correlate well with neuron loss (Schmitz et al 2004). However, 
a majority of researchers support the alternative hypothesis that amyloid-β (Aβ) is the 
primary causative agent (Mudher et al 2002).  
 
The amyloid hypothesis is initially compelling because the gene for the amyloid 
precursor protein (APP) is located on chromosome 21, and patients with trisomy 21 
(Down Syndrome) who thus have an extra gene copy almost universally exhibit 
Alzheimer’s disease-like disorders by 40 years of age (Nistor et al 2006, Lott et al 2005). 
The traditional formulation of the amyloid hypothesis points to the cytotoxicity of mature 
aggregated amyloid fibrils, which are believed to be the toxic form of the protein 
responsible for disrupting the cell's calcium ion homeostasis and thus inducing apoptosis 
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(Yankner et al 1990). A more recent and widely supported hypothesis suggests that the 
cytotoxic species is an intermediate misfolded form of amyloid-β (Aβ), neither a soluble 
monomer nor a mature aggregated polymer but an oligomeric species (Blanchard et al 
2000). Relevantly, much early development work on lead compounds has focused on the 
inhibition of fibrillization (Blanchard et al 2004, Porat et al 2006, Kanapathipillai et al 
2005), but the toxic-oligomer theory would imply that prevention of oligomeric assembly 
is the more important process (Lee et al 2005) or that a better target lies upstream, for 
example in the inhibition of amyloid precursor protein (APP) processing to amyloid-β 
(Aβ) (Espeseth et al 2005).  
 
It should be noted further that ApoE4, the major genetic risk factor for Alzheimer’s 
disease, leads to excess amyloid build up in the brain cortex and hippocampus before 
Alzheimer’s disease symptoms arise. Thus, amyloid-β (Aβ) deposition precedes clinical 
Alzheimer’s disease (Polvikoski et al 1995). Another strong support for the amyloid-β 
(Aβ) hypothesis, which looks at amyloid-β (Aβ) as the common initiating factor for 
Alzheimer's disease, is that transgenic mice solely expressing a mutant human amyloid 
precursor protein (APP) gene develop first diffuse and then fibrillar amyloid plaques, 
associated with neuronal and microglial damage (Games et al 1995, Masliah et al 1996, 
Hsiao et al 1996). 
 
The identification of the amino acid sequence for amyloid-β (Aβ) allowed cloning of its 
cognate protein, amyloid precursor protein (APP), and further confirmed it was a type I 
membrane protein resembling cell surface receptors. The majority of the current research 
is based on the “amyloid cascade hypothesis”. It states that accumulation of amyloid-β 
(Aβ) peptide is the initiating event that triggers neuro-degeneration in both sporadic 
Alzheimer’s disease cases and familial Alzheimer’s disease cases. The accumulation is 
triggered by either overproduction, mutated processing, or mutated clearance of the 
amyloid peptide, and consequently leads to self association of amyloid-β (Aβ) as neuro-
toxic fibrils. In recent years, genetic researches, which aim to link familial Alzheimer’s 
disease mutation reported so far to the proteolytic events that generate amyloid-β (Aβ), 
further confirm the amyloid-β (Aβ) cascade hypothesis. There are plenty of evidences 
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which show that all the amyloid precursor protein (APP) pathogenic mutations are 
clustered near the β-secretase and γ-secretase cleavage sites (Evin et al 2002, St George-
Hyslop 2000). Particularly, presenilin genes that encode essential components of the γ-
secretase proteolytic complex, have the highest probability of familial Alzheimer’s 





The γ-secretase proteolytic complex consists of four integral membrane proteins, namely 
presenilin, nicastrin, APH-1 and PEN-2. Presenilin includes PS1 and PS2 proteins. From 
a structural perspective, presenilin contains eight or nine transmembrane domains and 
two hypophlic aspartate residues in transmembrane domains which are suggested to form 
the catalytic site of the enzymic complex. Nicastrin consists of a single transmembrane 
domain and is highly glycosylated in the γ-secretase proteolytic complex. It has been 
reported that the DYIGS motif plays an essential role for the recognition of the γ-
secretase substrates. APH-1 consists of seven transmembrane domains. The homologous 
proteins of APH-1a and APH-1b are the typical forms of APH-1 protein. PEN-2 is the 
presenilin enhancer, which consists of two transmembrane domains and is an integral 
component for the endoproteolysis of presenilin.  
 
APH-1, PEN-2, presenilin, and nicastrin exist in at least three major states during initial 
assembly and subsequent maturation of the active γ-secretase proteolytic complex, the 
initial unassembled immature components, the immature complex and the mature and 
active complex. Biological studies suggest that APH-1 functions as a molecular scaffold 
for γ-secretase proteolytic complex. Transition of the immature complex to mature 
complex is associated with a presenilin endoproteolysis triggered conformational change. 
Motif mutations prevent APH-1 from performing its scaffolding role in initial assembly 
of the immature complex. APH-1, PEN-2, presenilin and nicastrin have multiple contacts 




Initially found through linkage studies using mutations present in familial Alzheimer’s 
cases in 1995 (Sherrington et al 1995), presenilins are a group of related multiple 
transmembrane proteins that function as a part of the γ-secretase proteolytic complex. 
Vertebrates species have two presenilin genes, namely PSEN1, located on chromosome 
14 in humans, that encodes presenilin 1 (PS-1) and PSEN2, on chromosome 1 in humans, 
that codes for presenilin 2 (PS-2). Both genes contain conservation among species, with 
little difference between rat and human presenilins. The Caenorhabditis elegans has two 
genes that represent the presenilins and appear to be functionally similar, sel-12 and hop-




Figure 3. Presenilin-1 structural model. Presenilins will be cleaved in the 
α helical region of one of cytoplasmic loops between transmembrane 
domain 6 and transmembrane domain 7 to produce a larger N-terminal and 





Presenilins will be cleaved in the α helical region of one of cytoplasmic loops between 
transmembrane domain 6 and transmembrane domain 7 to produce a larger N-terminal 
and a smaller C-terminal fragment which will create part of the functional protein. 
Cleavage of presenilin 1 can be prevented by a mutation which causes the loss of exon 9, 
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and consequently results in loss of functionality. Mutations in the presenilin proteins are 
known to cause early onset Alzheimer's disease through mechanisms which are of great 
interests to scientists. 
 
Recent research has produced a more widely accepted model with respect to the structure 
of presenilin-1. When initially investigated, the presenilin-1 gene was subjected to 
hydrophobicity analysis which predicted that the protein would contain ten trans-
membrane domains. All previous models agreed that the first six putative transmembrane 
spanning regions cross the membrane. These regions correspond to the N-terminal 
fragment of presenilin-1 but the structure of the C-terminal fragment had been in 
investigation for an extended period of time. Due to the nature of presenilin-1with large 
numbers of hydrophobic regions, it is inconvenient for x-ray crystallography to determine 
a definitive proof of the three dimensional structure. 
 
Generally, speaking, a significant percentage of the cases of Alzheimer's disease are not 
hereditary. However, there are a small percentage of cases that have an earlier age of 
onset and have a strong genetic influence. From patients of Alzheimer's disease, 
mutations in the presenilin proteins either presenilin-1 or presenilin-2 or the amyloid 
precursor protein (APP) can be tracked down. A significant percentage of these cases 
consists of mutant presenilin genes, either presenilin-1 or presenilin-2. An important part 
of the disease pathogenesis in Alzheimer's disease is the accumulation of Amyloid-β (Aβ) 
protein. To form Amyloid-β (Aβ) protein, amyloid precursor protein (APP) must be 
cleaved by two secretase enzymes, β-secretases and γ-secretase. Presenilin is the 
underlying substrate of γ-secretase that is responsible for the cleavage of amyloid 
precursor protein (APP) by γ-secretase. 
 
γ-secretase can cleave amyloid precursor protein (APP) at several points within a small 
region of the protein which results in Amyloid-β (Aβ) protein of various lengths. The 
lengths associated with Alzheimer’s disease are normally 40 and 42 amino acids long. 
Aβ-42 is more likely to aggregate to form plaques in the brain than Aβ-40. Presenilin 
mutations lead to an increase in the ratio of Aβ-42 produced compared to Aβ-40, 
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although the total quantity of Amyloid-β (Aβ) protein produced remains constantly 






Figure 4. Nicastrin structural model. Nicastrin is an integral component of 
the γ-secretase proteolytic complex involved in processing amyloid 
precursor protein (APP) to the Alzheimer's disease associated peptide 
Amyloid-β (Aβ) peptides. 
 
 
Nicastrin, or abbreviated as NCT, is a protein that is an integral component of the γ-
secretase proteolytic complex, which is one of the proteases involved in processing 
amyloid precursor protein (APP) to the Alzheimer's disease associated peptide Amyloid-
β (Aβ) peptides. The other proteins involved in the proteolytic complex are presenilin, 
which is the catalytically active component of the γ-secretase proteolytic complex, APH-
1, and PEN-2 (Kaether et al 2006). Nicastrin by itself is not catalytically active, but has 
the capacity to promote the maturation and proper trafficking of the other proteins in the 
γ-secretase proteolytic complex. All of them will experience significant post-translational 
modification before becoming catalytically active in the cell (Zhang et al 2005). Besides 
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the role in amyloid precursor protein (APP) pathway, nicastrin has also been identified as 
a regulator of neprilysin, an enzyme involved in the degradation of Amyloid-β (Aβ) 






Figure 5. Anterior pharynx-defective 1 structural model. APH-1 is a 
protein gene product originally identified in the Notch signaling pathway 




Anterior pharynx-defective 1, or abbreviated as APH-1, is a protein gene product 
originally identified in the Notch signaling pathway in Caenorhabditis elegans as a 
regulator of the cell surface localization of nicastrin (Goutte et al 2002). APH-1 
homologs in other organisms, including humans, have since been identified as 
components of the γ-secretase proteolytic complex along with the catalytically active 
presenilin and the regulatory nicastrin and PEN-2. The γ-secretase proteolytic complex is 
a multimeric protease responsible for the intracellular proteolysis of transmembrane 
proteins such as the Notch protein and amyloid precursor protein (APP). γ-secretase 
cleavage of amyloid precursor protein (APP) is one of two proteolytic steps necessary to 
generate the peptide of Amyloid-β (Aβ). The Amyloid-β (Aβ) misfolded form is 
implicated in the pathogenesis of Alzheimer's disease (Kaether et al 2006). All of the 
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components of the γ-secretase proteolytic complex experience extensive post-
translational modification, especially proteolytic activation. APH-1 and PEN-2 are 
considered as regulators of the maturation process of the catalytic component presenilin 
(Luo et al 2003). APH-1 consists of the α helical interaction motif glycine-X-X-X-
glycine (GXXXG) that is essential to both assembly of the γ-secretase proteolytic 





Figure 6. Presenilin enhancer 2 structural model. PEN-2 is a protein that 
is a regulatory component of the γ-secretase proteolytic complex 
responsible for proteolysis of amyloid precursor protein (APP). 
 
 
Presenilin enhancer 2, abbreviated as PEN-2, is a protein that is a regulatory component 
of the γ-secretase proteolytic complex, the one responsible for proteolysis of 
transmembrane proteins such as the Notch protein and amyloid precursor protein (APP). 
The γ-secretase proteolytic complex consists of PEN-2, APH-1, nicastrin, and the 
catalytic subunit presenilin (Kaether et al 2006). PEN-2 is a 101 amino acid integral 
membrane protein with a topology structure such that both the N-terminus and the C-
terminus face first the lumen of the endoplasmic reticulum (ER) and later the 
extracellular environment (Francis et al 2002). Numerous evidences have shown that a 
conserved sequence motif D-Y-L-S-F at the C-terminus, as well as the overall length of 
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the C-terminal tail, is required for the formation of an active gamma secretase complex 





Discovered in 1917 by Thomas Hunt Morgan when it was first noticed in a strain of the 
Drosophila melanogaster, its molecular analysis and sequencing has been widely studied 
in the 1980s. The Notch signaling pathway is a highly conserved cell signaling system in 
most multicellular organisms. Rather than crossing the membrane multiple passes 
between the extracellular and intracellular spaces, the notch receptor is a single-pass 




Besides the cleavage role of Amyloid-β (Aβ) peptides formation in γ-secretase 
proteolytic complex, presenilins are also implicated in the processing of notch, an 
important developmental protein. Mice that have the PS1 gene knocked out die early in 
development from developmental abnormalities similar to those found when notch is 
disrupted (Shen et al 1997). Together with nicastrin, APH-1 and PEN-2, these four 
proteolytic complex is essential for Notch signaling pathway in Caenorhabditis elegans 
embryos and is required for intramembrane proteolysis of Notch and β-amyloid precursor 
protein in mammalian cells. 
 
The Notch protein sits like a trigger spanning the cell membrane, with part of it inside 
and part outside. Ligand proteins binding to the extracellular domain induce proteolytic 
cleavage and release of the intracellular domain, which enters the cell nucleus to alter 





The Notch signaling pathway is essential for cell-cell communication. Notch signaling 
has also been involved in several processes that control multiple cell differentiation. 
Notch signaling is required for physiological angiogenesis and may promote tumor 
angiogenesis. A variety of strategies for blocking Notch signaling, in particular γ-
secretase inhibition, are discussed as potential therapies for breast cancer and tumor 
angiogenesis. During the formation of the valve primordial and ventricular development 
and differentiation, notch regulates crucial cell communication events between 
endocardium and myocardium (Joaquín et al 2007). In the developing cardiac cushion, 
Notch signaling plays an essential role in the activity of the cardiac valve homeostasis 
and has implications in other human disorders involving the cardiovascular system. 
Meanwhile, notch signaling is often repressed in many cancers, and faulty Notch 
signaling is implicated in many diseases.  
 
 
2.3.3 Notch Cascade 
 
Because most ligands are also transmembrane proteins, the receptor is normally only 
triggered from direct cell to cell communication. Groups of cells can arrange themselves 
in such a way that if one cell expresses a given character, it can be switched off in 
neighbor cells by the intercellular Notch signal. This is how the majority of cells 
communicate one another to make large structures. 
 
The Notch cascade consists of Notch and Notch ligands, as well as intracellular proteins 
transmitting the Notch signal to the cell's nucleus. The Notch receptor family is involved 




2.4 A Bioinformatic Solution 
 
In the research area of computational biology, sequence alignment is a method to derive 
the arrangement of sequences of DNA, RNA and protein sequence on the symbol-wise 
base-pair comparison basis so that the maximum similarity between sequences can be 
discovered. The biological implication is that we could now identify potential functional, 
systematic and phylogenetic relationships between the sequences. Under most 
circumstances, a matching equation with some data score value is used to measure how 
well two or more residue sequences can be aligned. The matching equation is related to 
the total occurrence of mismatch symbols or match symbols either on a percentage basis 
or an absolute score value with specific emphasis on special matching or mismatching. 
Gaps are defined as the blank spaces inserted between the nucleotide or amino acid 
residues to justify or align them with optimal matching score value. There are several 
existing approaches to solve either the global sequence alignment or the local sequence 
alignment. Theoretically speaking, the comparison between the test sequences and the 
sequence corpus database might uncover the potential motifs and domains within the test 
sequences. However, numerous evidences indicate there are more complicated 
mechanisms behind the wall. A straightforward alignment might not thoroughly reveal 
the background information.  
 
Increasing numbers of observations and experiments indicate the inactivation of a certain 
gene has no major apparent phenotype and fitness changes of the species. In certain 
circumstance, the functionality of a gene can be seen as a replacement of another. The 
nature favors the redundancy of the genes. From an engineer's point of view, nature 
ensures that the major functionalities are substantially backed up in case of mechanical 
failure.  
 
The mutation or deletion of a single gene often has little phenotypic effects due to the 
existence of the duplicate genes and the alternative metabolic pathways, regulatory 
networks. Particularly, multiple pathways and multiple genes can encode a specific 
enzyme in a pathway. In the case of a deletion or mutation of some gene, these 
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mechanisms could compensate the loss of the functionality via another copy of the same 
genotypic contents. For S. cerevisiae, at least a quarter of those gene deletions that have 
no phenotype are compensated by the duplicate genes. The necessity of the duplicate 
genes plays an imperative role towards the robustness of the genes against null mutations, 
a mutation with no functional change. In Drosophila, seven of the neurogenic phenotype 
deletions are extremely similar at the transcription and sequence level sharing the basic 
motif of transcriptional regulators. They are non-essentially individually, suggesting the 
functional redundancy of the encoded gene products.  
 
Redundancy is wide spread in genomes of higher organisms. They are performing the 
same function and the inactivation of one of these genes has little or no effect on the 
biological phenotype. They present 4 cases that could explain why the genetic 
redundancy is common. A series of evidence show that redundancy itself appears to be a 
historical consequence of polyploidy in the vertebrate common ancestor. 
 
 
2.5 Redundancy and Immunology 
 
Just like redundancy is an imperative element in our routine daily life, it also performs a 
substantial role in our human mass body. Numerous evidences indicate that homologous 
genes and gene products often have redundant physiological functions. Complement is an 
integral part of innate immunity. It functions throughout the body, including the oral 
cavity. Complexity and redundancy are important to efficiently kill a wide range of 
pathogens, yet not cause destruction of host tissues. 
 
Increasing numbers of observations and experiments indicates the inactivation of a 
certain gene has no major apparent phenotype and fitness of the species. In certain 
circumstance, the functionality of a gene can be seen as a replacement of another. The 
nature favors the redundancy of the genes.  
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The wide distributed redundancy of mast cells and macrophage plays an important role in 
the inflammation and tumor cytotoxicity. It helps human body to recover from the 
bacteria infections. For S. cerevisiae, at least a quarter of those gene deletions that have 
no phenotype are compensated by the duplicate genes (Gu et al 2003). The necessity of 
the duplicate genes plays an imperative role towards the robustness of the genes against 
null mutations, a mutation with no functional change.  
 
Based on the comparative similarity of the induction kinetics of Nur77 and Nor-1 in T 
cells, the functional redundancy mechanism of the Nor-1 protein is used to explain the 
lack of a phenotype in the Nur77 mutant mice (Cheng et al 1997).  
 
The phenotype of the knock-out mice has been studied by analyzing exhaustively all the 
possible genotypic double mutant combinations (Heber et al 2000) so as to link the 
relation between complementation and redundancy. They successfully identified the 
redundancy between APLP2 , a member of the Amyloid Precursor Protein (APP) 
involved in Alzheimer's disease, and both other family members and corroborate a key 
physiological role for APLP2. It had been confirmed that the proteins may serve 
primarily overlapping functions and complement to each other (Koch et al 1997, 
Steinbach et al 1998, White et al 1998).  
 
The mutation or deletion of a single gene often has little phenotypic effects due to the 
existence of the duplicate genes and the alternative metabolic pathways, regulatory 
networks (Gu et al 2003). Particularly, it has been confirmed that, in Drosophila, seven of 
the neurogenic phenotype deletions are extremely similar at the transcription and 
sequence level sharing the basic motif of transcriptional regulators (Maier et al 1993). 
They are non-essentially individually, suggesting the functional redundancy of the 
encoded gene products. A series of evidence has proved that redundancy itself appears to 









Alignment of multiple biological sequences is one of the central problems in 
computational biology. Multiple sequence alignment has applications in various problems 
in biology, and can be applied respectively on DNA, RNA or protein sequences. Example 
applications can be found in whole-genome sequencing, identifying conserved regions 
and regulatory elements in related genomes, determining important regions for cite-
directed mutatgenesis, construction of and analysis of phylogenic trees, phylogenic 
footprinting, etc. An alignment of the sequences is obtained by inserting gaps at chosen 
positions in each of the sequences, such that the resulting sequences all have the same 
length. The sequences are thus arranged into an array of symbols, whereby no column is 
allowed to contain only gaps. The goodness of an alignment is measured by the 
alignment value, which is determined using a scoring function. The problem is therefore 
to determine the optimal alignment. A multiple sequence alignment will result in a 
minimal alignment value.  The result is that the sequences are now arranged such that the 
maximal similarity between them are now exposed, and can be exploited for various 
applications. 
 
The problem of computing the optimal alignment for multiple sequences is known to be 
NP-complete, and thus various heuristics and approximations have been proposed. Most 
methods are typically based on either global alignments, or local alignment. Hybrid 
approaches aimed at integrating both local and global methods have also been reported. 
Example popular alignment programs include CLUSTAL W and its family, T-COFFEE, 
DIALIGN and its derivatives, MUSCLE, Align-m, GAME, etc. Gusfield and Mount 




We propose a sort based method for constructing multiple sequence alignments. Our 
motivation is the recent result in linear time direct suffix sorting, whereby suffix arrays 
can be constructed in linear time and space in the worst case, without the need to first 
construct suffix trees. This has important implications for both the time required for 
computing the alignment, and the space needed for constructing the suffix arrays. We 
perform alignment by first identifying a set of anchor points, based on the suffix sorting 
output on the sequences. Final alignment and gap considerations can be made by a 
recursive application of the sort-based anchor point algorithm. 
 
An important novelty in our approach is how biological mutation information is 
incorporated in each refinement step. Thus, the recursive alignment refinement is 
performed via sorting and alignment between anchor points using a biological mutated 
version of the original sequences. This sort-mutate-anchor paradigm separates our 
proposed sequence alignment algorithm from other previously proposed techniques. 
In the next section, we briefly describe related work on sequence alignment, with 
emphasis on anchor-based methods. The following section presents a brief overview on 
linear time direct suffix sorting, the basis of our approach. Our algorithm is presented, 
along with an analysis of its results. 
 
3.2 Methods 
An approach that has been used to reduce the complexity of multiple sequence alignment 
is by the use of selected anchor points along the sequences. An anchor point is defined by 
the sequences involved in the anchor, the starting position of the anchor in the sequences, 
and the length of the anchor. In some situations, especially with user-defined anchors, the 
anchors are given priorities, which can help the algorithm in resolving consistency 
between the anchors. Anchor priorities can also be used to determine which anchor points 
should be chosen first, where there are multiple anchor points in the same region. 
Anchors help to restrict the search required in performing the alignment, by constraining 
the required search to only regions between two anchor points. Clearly, the performance 
of anchor-based algorithms depends critically on how the anchor points are chosen, and 
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to some extent, on how the alignment between anchor points is performed. The sequences 
involved in the alignment are represented as horizontal lines. The vertical lines indicate 
where an anchor has been established between sequences. Solid vertical lines represent 
strong anchors, while the dotted lines depict weak anchors.  
 
Various anchor-based methods have been proposed. The methods differ in the way the 
anchor points are defined, in how they are computed, whether or not priorities are 
assigned, and in how the remaining sequences between anchors are aligned. The clusters 
observed in the sorted common prefix (SCP) data structure were proposed for 
determining regions for anchor point computations, using the notion of sphere of 
influence for the anchor points.  
 
A maximum unique match (MUM) is a subsequence that occurs only once in each of the 
sequences involved in the alignment, and it is not contained in any other MUM. Here, the 
MUMs are used to form anchor points for the alignment.  The use of MUMs follows the 
idea used in popular alignment programs such as BLAST and FASTA. Conceptually, if 
there is an MUM between the input sequences, it is most likely to be part of the global 
alignment. One problem with MUM-based alignment is that it does not work well in 
aligning sequences from relatively distant species. The basic idea has been modified, for 
instance, using criteria different from MUMs. Example, GAME used maximal exact 
matches (MEMs), rather than MUMs, while in LAGAN, Brudno et al used the idea of 
anchors, whereby anchor points are defined based on inexact matches.  
 
In ACANA, anchors are determined by using the edit matrix produced during dynamic 
programming. By choosing near-optimal local alignments along the diagonals of the 
dynamic programming matrix, they recursively determine the best anchors for global 
alignment for each region, which are then fixed for the region. Final alignment is 
produced by connecting each region with the fixed anchor points.  
 
Another way to view the anchors is in terms of constraints on the sequences to be aligned. 
Such constraints could be user-defined, or could be machine generated based on some 
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application dependent information. Myers et al proposed methods for progressive 
alignment incorporating sets of constraints, and studied the issue of consistency between 
constraints. Brown and Hudek proposed a tree-based method for anchor-based 
progressive alignment using spaced or seeded anchors. Spaced anchors are constraints in 
the alignment defined in terms of a binary pattern over the sequences, such that matches 
or mismatches can be allowed at a given position along the sequences, based on whether 
we have say a 1 or 0 at the given position. Sequence alignments using explicit user 
defined anchors were studied. 
 
While user-defined constraints can be quite important in some applications, this makes 
the methods less flexible, especially in using the algorithms on applications different 
from their original purpose. Moreover, for very large sequences, for instance, whole 
genomes, or when many sequences are involved, defining these manual anchor points 
may become difficult. Automated anchor point determination will thus be needed in such 
situations. Such automated methods should be able to provide options for augmenting the 
automatically determined anchor points with user-specified anchors. Similar ideas can be 
used to incorporate further expertise, for instance, knowledge of locally conserved 
protein secondary structures, as constraints in the alignment.  
 
3.2 The Problem and Main Contribution 
The computational problem in multiple sequence alignment is often due to the model 
used for inducing gaps during the alignment. This is because the optimal alignment often 
requires an exhaustive evaluation of all the possibilities for gap insertion in the sequences 
being aligned. In fact, from one view point, the problem of sequence alignment can be 
viewed as that of appropriate gap induction within the sequences involved. For anchor-
based alignment schemes, an additional problem is the selection of anchor points, and the 
development of appropriate anchor scoring functions to be used.  
 
The major contribution of this work is a mechanism to cut down on the exhaustive search 
required for gap induction. The method we propose is anchor-based, whereby anchors are 
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determined based on the sorted suffixes and position-based analysis. In particular, we 
propose a sort-based alignment algorithm, using methods of linear-time worst-case suffix 
sorting as our basic building block. The sorts implicitly expose where alignments should 
be anchored, and which regions are not likely to form an alignment, thereby eliminating 
the need for exhaustive gap insertion and alignment score evaluation. We also develop a 
new anchor-point evaluation scheme based on the sorted suffixes, position-based sorts, 
and a proposed mutation mapping scheme. 
 
After the initial sorting on the original sequences, we extend the sort-based approach 
using a novel mutation mapping scheme. Here, symbols are mutated based on a mutation 
map derived from standard mutation matrices, and the sorting procedures (suffix sorting 
and position-based sorts) on symbols between anchors are now performed on these 
mutated symbols. New anchor points are then determined within the previous anchors. 
Fixing the anchor points implies that subsequent steps can not change these anchors. 
Later alignment steps can only be performed on symbols within the same anchor region. 
Operations on symbols in two different anchor regions are forbidden. Sequence 
alignment is then performed as a recursive application of this sort-mutate-anchor 
paradigm on the symbols between each pair of anchor points. 
 
3.3 Motif Determination 
We propose a sort-based multiple sequence alignment algorithm. Based on the 
observation that a well matched alignment is also a rearrangement of highly repetitive 
segments and non-repetitive region across all the source sequences, the algorithm 
transforms the alignment for multiple sequences into a long range repetitive pattern 
identification problem where the advantage of the automated suffix sorting technique can 
be fully exploited. Since suffix sorting could reveal the repetition information across all 
sequences, we can home on the anchor points with the aid of suffix arrays. By 
constructing both strong and weak connections, the algorithm builds restraints to cross 
and align different sequences by their anchor points. By recursive repetition of the 
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procedure using information from biological substitution matrices, the global alignment 
for multiple sequences can be obtained.  
 
3.3.1 Overview 
We provide a generalized outline of the proposed algorithm. It includes subroutines of the 
source sequence concatenation, suffix sorting, anchor points identification and biological 
substitution matrices decomposition. The proposed algorithm takes advantage of suffix 
sorting by converting inter-sequences vertical alignment problem to one dimension 
horizontal repetitive pattern identification using suffix sorting. The general idea is to 
concatenate multiple source sequences into a simple sequence with special end-of-
sequence symbols, then perform the suffix sorting. This sorting operation exposes the 
repetitive segments across the source sequences. We evaluate the suitability of these 
repetitive segments for anchor point’s formation by computing their anchor scores. The 
segments with anchor scores above a threshold are marked as potential anchor regions. 
The starting position of each potential anchor region is a potential anchor point. The 
maximum valued anchor points are first selected and fixed onto the blank backbone 
sequences. Recursively, a less tightly correlated anchor point identification subroutine is 
performed between those previous identified anchor regions until all the anchor regions 
are exhausted.  
 
3.3.2 Motif Selection 
A one-to-one mapping relation has been noted from the sequence concatenation operation. 
The suffix sorting routine is then applied on the simple sequence. This will produce the 
suffix which contains all the suffixes, sorted according to their alphabetical orders. 
Essentially, input sequence will be partitioned, whereby each group contains suffixes that 
start with the identical symbol. This will create the re-sorted motif arrays. Given the one-
to-one mapping, each suffix can be marked. 
 
A sliding window is introduced to elaborate the anchor point selection process. The 
sliding window is defined as a covered region such that all suffixes fall into this region 
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can be factored to determine the anchor point. This region is marked which indicates the 
boundary of the potential anchor points. Anchor score for anchor point within the region 
Q is computed as shown in the downward sliding. The sliding window is then shifted to 
the next suffix by incrementation, namely sliding down the window by one. The new 
sliding window covers the region. A similar computation of anchor score can be obtained 
as well. The values are listed to the right of each sliding. The anchor score computation 
steps are repeated until the sliding window reaches the bottom of each. The algorithm 
will proceed to the next group after it finishes the designated group until all groups are 
processed. The suffix sorting routine is applied on sequence. Suffix is marked as being 
sorted, based on the alphabetical order. Suffix is marked with its corresponding positions.  
 
3.4 Motif Determination with Mutation 
 
One of the disadvantages of direct anchor point sorting is that it only identifies the 
strongest anchor points across the source sequences. The implicit structural and 
functional significance of biological sequence cannot be fully exploited. We introduce the 
biological mutation matrices of BLOSUM and PAM to further refine the multiple 
sequence alignment results between two consecutive strong anchor points. These 
matrices calculate a log-odds score for all possible substitutions of the $20$ standard 
amino acids with typical applications in sequence alignment and multiple sequence 
alignment. Both BLOSUM62 and PAM250 are two widely referred biological mutation 
matrices. BLOSUM62 is the calculated matrix by using the observed substitutions 
between proteins which have 62 or more sequence identity. PAM250 means a 250 point 
mutations/100 amino acids which gives the different rates of mutations between pairs of 
amino acids. 
 
After obtaining the preliminary results, the mutation-based suffix sort will continue to 
further refine the segmental alignment between two consecutive pre-determined anchor 
points. The biological mutation matrix will be introduced at this stage. The matrix 
denotes the different rates of mutations between pairs of amino acids. Notice the matrix is 
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a symmetric matrix. We can group the edges. Because the symmetric property of matrix, 
we define the mutation from alphabetically greater symbol to alphabetically smaller. We 
define group to contain all mutated vertices where there are parallel edges between each 
other. The grouping table is to be used in the mutation-based suffix sorting routine. This 
grouping table depends on the biological mutation table only and it is independent of the 
input source sequences. The table will be produced once during the alignment procedure. 
 
Because the strong anchor points have been fixed in the first suffix sorting routine, the 
mutation based suffix sorting will be applied on the regions between two consecutive 
strong anchor points in a decreasing order. The suffix sorting routine is applied on the 
regions after each group mutation operation. The mutation information will be written to 
a supplemental table in order to recover the mutated sequences back to the origin during 
the finalizing steps. 
 
The suffix sorting routine is performed after the mutation. This will anchor the group in 
the regions. A suffix sort after the mutation then produces the anchor points. 
Continuously performing the mutation, the algorithm will reach a stage when no more 
anchor sites can be found to achieve a positive profit gain. At this stage, for any regions 
between two adjacent anchor sites, the blank gap spaces are always at the end of the 
segment because whenever the algorithm tries to align a local anchor site, it always to 
shift the anchor sites to the left and seek fitness and adaptation. Following the mutation 
information, the algorithm performs the mutation once for each unique value and stores 
the mutation information into the complementary table. The complementary table will be 
used to recover the alignment to the original input source sequences after all mutations 
have been finished. The mutation is performed in the decreasing order such that the 
symbols with stronger affinity will be anchored first. 
 
Each subsequence is recursively aligned within its individual anchor region following the 
mutation based suffix sorting routine. After each regional alignment is achieved, they are 
concatenated based on the strongest anchor points. The final results are obtained through 
concatenation of the regional alignment results from anchor points. 
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The traditional bottleneck in alignment is the search for gap positions. Notice that we do 
not perform direct search for best positions for gap insertion at each stage. With our 
approach to gap induction, it means that the traditional problem of exhaustive search for 
nest positions for gap insertion has now been transformed to the problem of searching for 
best anchor points. The problem of best positions for gap insertion is handled implicitly 
by the sorting stage and the mutation-mapping procedure. 
 
As the sliding window moves along with the anchor sites, some anchor points might be 
found to be closer to some previously fixed anchor sites on the consensus sequence. The 
proposed algorithm will meet the creation of both anchor sites by insertion of gaps. The 
induction of gaps avoids the possibility of assigning two anchor points on the same 
location of the consensus sequence. Whenever two anchor points are identified on the 
same location of the consensus sequence, the alphabetically smaller anchor point is fixed 
at the current location and the alphabetically greater anchor point is fixed at the location 
next to the current one to the right. The algorithm fills the corresponding space with gaps 
across different sequences. 
 
3.5 Conclusion 
We proposed a suffix sorting-based multiple-sequence alignment algorithm with anchor 
points. We simplify the alignment score functions so as to better reflect the actual 
implication. We analyze the complexity requirements of the proposed algorithm. We 
correctly test the proposed algorithm on benchmark sequence data so far. Meanwhile, we 
apply the mutation based alignment scheme into the current algorithm. The current 
algorithm treats each individual mismatch uniformly. However, we believe that 






4. Motifs of γ-Secretase and Its Substrates 
 
In this study, we employ the designed bioinformatic software packages to study the target 
motif substrates of γ-secretase and those relevant domains. As known in most publication, 
γ-secretase contains four types of components of Presenilin, APH-1, Pen-2 and Nicastrin. 
We apply the sequence scanning technique to all of these four component sets. We 
collect the sequence data for the four γ-secretase substrates from NCBI official database. 
Mutiple species sequence data are collected to cross examine the target motif substrates 
and domain information. Without loss of generality, we take Nicastrin as an example. 





Figure 7. Speculative Motif sites of Nicastrin [Homo Sapiens]. 
 
 
We pass the Nicastrin [Homo Sapiens] to the motif finding program. There are 3 groups, 
totalling 5 motifs identified. Three groups include one motif of tyrosine kinase group, one 
motif of basophilic serine/threonine kinase group and three motifs of kinase binding site 
group. Their gene cards' ID codes are also maintained. Meanwhile, there is one 
Nicastrin(196-256) domain associates with the input sequence. Through the sequence 




Meanwhile, we also apply the multiple sequence techniques to estimate the Nicastrin 
motifs identification. Through this method, we pass the Nicastrin [Homo Sapiens] 
domain sequences to the multiple sequence alignments and hidden Markov models 
covering many common protein domains and families. We are able to successfully 
identify the DYIGS groups, which are reported by the γ-secretase review paper. The 
DYIGS groups are marked in blue in the multuple sequence alignment table. Besides that, 
we also identify some potential motif sites, as marked in red in the following tables. We 
identify E will occur two spaces before DYIGS, forming E-DYIGS pair. E (Glutamic 
acid) is then speculated to be located two spaces before DYIGS. Glutamic acid might 
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query_196-256         ~~~~~~~~~~ ~~~~~~~~~~ ~~~~~~~~~~ ~~~~~~~~~~ ~~~~~~~~~~ 
Q7KS07_DROME_236-469  KFILVTCRLD TTTMFDGVGL GAMDSLMGFA VFTHVAYLL. ...KQLLPPQ 
Q7PY38_ANOGA_276-510  RIVLVSTRTD TTTMFDGVGL GAMDSVVPFA VLVAVAHFL. ...SQALP.. 
NICA_MOUSE_273-498    RVVVAATRLD SRSFFWNVAP GAESAVASFV TQLAAAEAL. ...HKA.PDV 
NICA_ARATH_251-460    PVVLTVASMD TASFFRDKSF GADSPISGLV ALLGAVDAL. ...SRV.DGI 
Q6Z743_ORYSA_248-457  PIIMVTASQD SASFFRDRSL GADSPISGLI ALLTAVDAL. ...SHL.HDI 
NICA_CAEEL_278-508    KYMMVTARMD SFGMIPEISV GEVSVLTSII SVLAAARSMG TQIEKWQKAS 
 
                      51                                                 100 
query_196-256         ~~~~~~~~~~ ~~~~ETFDYI GSSRMVYDME KGKFP..... .......VQL 
Q7KS07_DROME_236-469  SKDLHNVLFV TFNGESYDYI GSQRFVYDME KLQFP....T ESTGTPPIAF 
Q7PY38_ANOGA_276-510  SND.RNVLFL FFNGESYDYI GSQRFVYDLQ TGAFP....S RGTQTKPISM 
NICA_MOUSE_273-498    TTLSRNVMFV FFQGETFDYI GSSRMVYDME NGKFP..... .......VRL 
NICA_ARATH_251-460    SNLKKQLVFL VLTGETWGYL GSRRFLHELD LHSDA..... ....VAGLSN 
Q6Z743_ORYSA_248-457  SNLKKQLVFA VFNGEAWGYL GSRKFLQELD QGADS..... ....VNGISS 
NICA_CAEEL_278-508    NTSNRNVFFA FFNGESLDYI GSGAAAYQME NGKFPQMIRS DRTHIHPIRP 
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query_196-256         ENVDSFVELG QVALRTSLE. ..LWMHTDPV SQKNESVRNQ ~~~~~~~~~~ 
Q7KS07_DROME_236-469  DNIDFMLDIG TLDDISN... ..IKLH.... ALNGTTLAQQ ILERLNNYAK 
Q7PY38_ANOGA_276-510  DNIELMIDLG ALDNLTD... ....LHVY.. HAAPQPMATK VAELLRKINQ 
NICA_MOUSE_273-498    ENIDSFVELG QVALRTSLD. ..LWMHTDPM SQKNESVKNQ VEDLLATLEK 
NICA_ARATH_251-460    TSIETVLEIG SVGKGLSGGI NTFFAH.... KTRVSSVTNM TLDALKIAQD 
Q6Z743_ORYSA_248-457  LLIDQVLEIG SVGKAISQGY PLFYAH.... AAGNSSISMK MVDALQSASE 
NICA_CAEEL_278-508    NELDYILEVQ QIGVAKGRK. ..YYVHVD.. GERYQQNKTQ TDRVIDRIER 
 
                      151                                                200 
query_196-256         ~~~~~~~~~~ ~~~~~~~~~~ ~~~~~~~~~~ ~~~~~~~~~~ ~~~~~~~~~~ 
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Q7KS07_DROME_236-469  SPRYGFNLNI .QSEMSAHLP PTSAQSFLRR DPNFNALILN ARPT...NKY 
Q7PY38_ANOGA_276-510  QFGFGIQAGQ PVMTTN..LP PVSAQSFLRE NITFPAVIVA SRPA...NRF 
NICA_MOUSE_273-498    SGAGVPEVVL RRLAQSQALP PSSLQRFLRA R.NISGVVLA DHSGSFHNRY 
NICA_ARATH_251-460    SLASKNIKIL SADTANPGIP PSSLMAFMRK NPQTSAVVLE DFDTNFVNKF 
Q6Z743_ORYSA_248-457  SLGSDNVKVK PAASSNPGVP PSSLMSFLGK NSSTPGLVLE DFDSQFSNRF 
NICA_CAEEL_278-508    GLRSHAFDLE KPSGSGDRVP PASWHSFAKA DAHVQSVLLA PYGKEYEYQR 
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query_196-256         ~~~~~~~~~~ ~~~~~~~~~~ ~~~~~~~~~~ ~~~~~~~~~~ ~~~~~~~~~~ 
Q7KS07_DROME_236-469  YHSIYDDADN VDFTYANTSK ..DFTQLTEV N..DFKSLN. PDSLQMKVRN 
Q7PY38_ANOGA_276-510  YHSIYDDQEN LHYRYGNHSR KYDFTQLEDL DLGDRSDLYG KDSIQMRIRN 
NICA_MOUSE_273-498    YQSIYDTAEN INVTYPEWQS .......... ...PEEDLNF VTDTAKALAN 
NICA_ARATH_251-460    YHSHLDDLSN INS....... .......... .......... .....SSVVA 
Q6Z743_ORYSA_248-457  YHSTLDGPAN VNS....... .......... .......... .....SSIAA 
NICA_CAEEL_278-508    VNSILDKNE. .......... .......... ...WTEDERE KAIQEIEAVS 
 
                      251    
query_196-256         ~~~~~~~~~~ 
Q7KS07_DROME_236-469  VSSIVAMALY 
Q7PY38_ANOGA_276-510  ASSLIGMSIY 
NICA_MOUSE_273-498    VATVLARALY 
NICA_ARATH_251-460    AASVVARTLY 
Q6Z743_ORYSA_248-457  AAALIARSLY 
NICA_CAEEL_278-508    TAILAAAADY 
 
Table 1. Sequence alignment between Nicastrin [Homo Sapiens] and the other six sets of 
Nicastrin variation. DYIGS is reported from our measure as confirmed by the γ-secretase 
review paper. Some other similar motif patterns are also reported, which are marked in 
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                      1                                                   50 
query_274-499         RVVVAATRLD SRSFFWNVAP GAESAVASFV TQLAAAEAL. ...HKA.PDV 
Q7KS07_DROME_236-469  KFILVTCRLD TTTMFDGVGL GAMDSLMGFA VFTHVAYLL. ...KQLLPPQ 
Q7PY38_ANOGA_276-510  RIVLVSTRTD TTTMFDGVGL GAMDSVVPFA VLVAVAHFL. ...SQALP.. 
NICA_MOUSE_273-498    RVVVAATRLD SRSFFWNVAP GAESAVASFV TQLAAAEAL. ...HKA.PDV 
NICA_ARATH_251-460    PVVLTVASMD TASFFRDKSF GADSPISGLV ALLGAVDAL. ...SRV.DGI 
Q6Z743_ORYSA_248-457  PIIMVTASQD SASFFRDRSL GADSPISGLI ALLTAVDAL. ...SHL.HDI 
NICA_CAEEL_278-508    KYMMVTARMD SFGMIPEISV GEVSVLTSII SVLAAARSMG TQIEKWQKAS 
 
                      51                                                 100 
query_274-499         TTLSRNVMFV FFQGETFDYI GSSRMVYDME NGKFP..... .......VRL 
Q7KS07_DROME_236-469  SKDLHNVLFV TFNGESYDYI GSQRFVYDME KLQFP....T ESTGTPPIAF 
Q7PY38_ANOGA_276-510  SND.RNVLFL FFNGESYDYI GSQRFVYDLQ TGAFP....S RGTQTKPISM 
NICA_MOUSE_273-498    TTLSRNVMFV FFQGETFDYI GSSRMVYDME NGKFP..... .......VRL 
NICA_ARATH_251-460    SNLKKQLVFL VLTGETWGYL GSRRFLHELD LHSDA..... ....VAGLSN 
Q6Z743_ORYSA_248-457  SNLKKQLVFA VFNGEAWGYL GSRKFLQELD QGADS..... ....VNGISS 
NICA_CAEEL_278-508    NTSNRNVFFA FFNGESLDYI GSGAAAYQME NGKFPQMIRS DRTHIHPIRP 
 
                      101                                                150 
query_274-499         ENIDSFVELG QVALRTSLD. ..LWMHTDPM SQKNESVKNQ VEDLLATLEK 
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Q7KS07_DROME_236-469  DNIDFMLDIG TLDDISN... ..IKLH.... ALNGTTLAQQ ILERLNNYAK 
Q7PY38_ANOGA_276-510  DNIELMIDLG ALDNLTD... ....LHVY.. HAAPQPMATK VAELLRKINQ 
NICA_MOUSE_273-498    ENIDSFVELG QVALRTSLD. ..LWMHTDPM SQKNESVKNQ VEDLLATLEK 
NICA_ARATH_251-460    TSIETVLEIG SVGKGLSGGI NTFFAH.... KTRVSSVTNM TLDALKIAQD 
Q6Z743_ORYSA_248-457  LLIDQVLEIG SVGKAISQGY PLFYAH.... AAGNSSISMK MVDALQSASE 
NICA_CAEEL_278-508    NELDYILEVQ QIGVAKGRK. ..YYVHVD.. GERYQQNKTQ TDRVIDRIER 
 
                      151                                                200 
query_274-499         SGAGVPEVVL RRLAQSQALP PSSLQRFLRA R.NISGVVLA DHSGSFHNRY 
Q7KS07_DROME_236-469  SPRYGFNLNI .QSEMSAHLP PTSAQSFLRR DPNFNALILN ARPT...NKY 
Q7PY38_ANOGA_276-510  QFGFGIQAGQ PVMTTN..LP PVSAQSFLRE NITFPAVIVA SRPA...NRF 
NICA_MOUSE_273-498    SGAGVPEVVL RRLAQSQALP PSSLQRFLRA R.NISGVVLA DHSGSFHNRY 
NICA_ARATH_251-460    SLASKNIKIL SADTANPGIP PSSLMAFMRK NPQTSAVVLE DFDTNFVNKF 
Q6Z743_ORYSA_248-457  SLGSDNVKVK PAASSNPGVP PSSLMSFLGK NSSTPGLVLE DFDSQFSNRF 
NICA_CAEEL_278-508    GLRSHAFDLE KPSGSGDRVP PASWHSFAKA DAHVQSVLLA PYGKEYEYQR 
 
                      201                                                250 
query_274-499         YQSIYDTAEN INVTYPEWQS .......... ...PEEDLNF VTDTAKALAN 
Q7KS07_DROME_236-469  YHSIYDDADN VDFTYANTSK ..DFTQLTEV N..DFKSLN. PDSLQMKVRN 
Q7PY38_ANOGA_276-510  YHSIYDDQEN LHYRYGNHSR KYDFTQLEDL DLGDRSDLYG KDSIQMRIRN 
NICA_MOUSE_273-498    YQSIYDTAEN INVTYPEWQS .......... ...PEEDLNF VTDTAKALAN 
NICA_ARATH_251-460    YHSHLDDLSN INS....... .......... .......... .....SSVVA 
Q6Z743_ORYSA_248-457  YHSTLDGPAN VNS....... .......... .......... .....SSIAA 
NICA_CAEEL_278-508    VNSILDKNE. .......... .......... ...WTEDERE KAIQEIEAVS 
 
                      251    
query_274-499         VATVLARALY 
Q7KS07_DROME_236-469  VSSIVAMALY 
Q7PY38_ANOGA_276-510  ASSLIGMSIY 
NICA_MOUSE_273-498    VATVLARALY 
NICA_ARATH_251-460    AASVVARTLY 
Q6Z743_ORYSA_248-457  AAALIARSLY 
NICA_CAEEL_278-508    TAILAAAADY 
 
Table 2. Sequence alignment between Nicastrin [Mus musculus] and the other six sets of 
Nicastrin variation. DYIGS is reported from our measure as confirmed by the γ-secretase 
review paper. Some other similar motif patterns are also reported, which are marked in 
red above. "F - - F - G E - - D Y I G S" is speculated as a motif pattern, which might play 
an important functional role for "D Y I G S" group. "P P - S - - - F L R" and "N R - Y - S 
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                      1                                                   50 
query_284-508         EFIMVATRID SHSFFWNIAP GAESAVSSFV THLAAAEAL. ...HKA.SDV 
Q7KS07_DROME_236-469  KFILVTCRLD TTTMFDGVGL GAMDSLMGFA VFTHVAYLL. ...KQLLPPQ 
Q7PY38_ANOGA_276-510  RIVLVSTRTD TTTMFDGVGL GAMDSVVPFA VLVAVAHFL. ...SQALP.. 
NICA_MOUSE_273-498    RVVVAATRLD SRSFFWNVAP GAESAVASFV TQLAAAEAL. ...HKA.PDV 
 33
NICA_ARATH_251-460    PVVLTVASMD TASFFRDKSF GADSPISGLV ALLGAVDAL. ...SRV.DGI 
Q6Z743_ORYSA_248-457  PIIMVTASQD SASFFRDRSL GADSPISGLI ALLTAVDAL. ...SHL.HDI 
NICA_CAEEL_278-508    KYMMVTARMD SFGMIPEISV GEVSVLTSII SVLAAARSMG TQIEKWQKAS 
 
                      51                                                 100 
query_284-508         HLLQRNIMFT FFQGETFDYI GSSRMVYDME KDKFP..... .......LRL 
Q7KS07_DROME_236-469  SKDLHNVLFV TFNGESYDYI GSQRFVYDME KLQFP....T ESTGTPPIAF 
Q7PY38_ANOGA_276-510  SND.RNVLFL FFNGESYDYI GSQRFVYDLQ TGAFP....S RGTQTKPISM 
NICA_MOUSE_273-498    TTLSRNVMFV FFQGETFDYI GSSRMVYDME NGKFP..... .......VRL 
NICA_ARATH_251-460    SNLKKQLVFL VLTGETWGYL GSRRFLHELD LHSDA..... ....VAGLSN 
Q6Z743_ORYSA_248-457  SNLKKQLVFA VFNGEAWGYL GSRKFLQELD QGADS..... ....VNGISS 
NICA_CAEEL_278-508    NTSNRNVFFA FFNGESLDYI GSGAAAYQME NGKFPQMIRS DRTHIHPIRP 
 
                      101                                                150 
query_284-508         ENIHSFVELN QVALRNG... SILWMHTDPV SRLNATVEPQ VKNLLDILSN 
Q7KS07_DROME_236-469  DNIDFMLDIG TLDDISN... ..IKLH.... ALNGTTLAQQ ILERLNNYAK 
Q7PY38_ANOGA_276-510  DNIELMIDLG ALDNLTD... ....LHVY.. HAAPQPMATK VAELLRKINQ 
NICA_MOUSE_273-498    ENIDSFVELG QVALRTSLD. ..LWMHTDPM SQKNESVKNQ VEDLLATLEK 
NICA_ARATH_251-460    TSIETVLEIG SVGKGLSGGI NTFFAH.... KTRVSSVTNM TLDALKIAQD 
Q6Z743_ORYSA_248-457  LLIDQVLEIG SVGKAISQGY PLFYAH.... AAGNSSISMK MVDALQSASE 
NICA_CAEEL_278-508    NELDYILEVQ QIGVAKGRK. ..YYVHVD.. GERYQQNKTQ TDRVIDRIER 
 
                      151                                                200 
query_284-508         SSVGANITLQ .EVGFSQPLP PSSFQRFLRA R.HIPGVVLS DHQASFQNRY 
Q7KS07_DROME_236-469  SPRYGFNLNI .QSEMSAHLP PTSAQSFLRR DPNFNALILN ARPT...NKY 
Q7PY38_ANOGA_276-510  QFGFGIQAGQ PVMTTN..LP PVSAQSFLRE NITFPAVIVA SRPA...NRF 
NICA_MOUSE_273-498    SGAGVPEVVL RRLAQSQALP PSSLQRFLRA R.NISGVVLA DHSGSFHNRY 
NICA_ARATH_251-460    SLASKNIKIL SADTANPGIP PSSLMAFMRK NPQTSAVVLE DFDTNFVNKF 
Q6Z743_ORYSA_248-457  SLGSDNVKVK PAASSNPGVP PSSLMSFLGK NSSTPGLVLE DFDSQFSNRF 
NICA_CAEEL_278-508    GLRSHAFDLE KPSGSGDRVP PASWHSFAKA DAHVQSVLLA PYGKEYEYQR 
 
                      201                                                250 
query_284-508         YQSMYDTPEN IQMQYPEGLS .......... ...PEETLEY VTDTAKSLAE 
Q7KS07_DROME_236-469  YHSIYDDADN VDFTYANTSK ..DFTQLTEV N..DFKSLN. PDSLQMKVRN 
Q7PY38_ANOGA_276-510  YHSIYDDQEN LHYRYGNHSR KYDFTQLEDL DLGDRSDLYG KDSIQMRIRN 
NICA_MOUSE_273-498    YQSIYDTAEN INVTYPEWQS .......... ...PEEDLNF VTDTAKALAN 
NICA_ARATH_251-460    YHSHLDDLSN INS....... .......... .......... .....SSVVA 
Q6Z743_ORYSA_248-457  YHSTLDGPAN VNS....... .......... .......... .....SSIAA 
NICA_CAEEL_278-508    VNSILDKNE. .......... .......... ...WTEDERE KAIQEIEAVS 
 
                      251    
query_284-508         VATVVARALY 
Q7KS07_DROME_236-469  VSSIVAMALY 
Q7PY38_ANOGA_276-510  ASSLIGMSIY 
NICA_MOUSE_273-498    VATVLARALY 
NICA_ARATH_251-460    AASVVARTLY 
Q6Z743_ORYSA_248-457  AAALIARSLY 
NICA_CAEEL_278-508    TAILAAAADY 
 
Table 3. Sequence alignment between Nicastrin [Gallus gallus] and the other six sets of 
Nicastrin variation. DYIGS is reported from our measure as confirmed by the γ-secretase 
review paper. Some other similar motif patterns are also reported, which are marked in 
red above. "F - - F - G E - - D Y I G S" is speculated as a motif pattern, which might play 
an important functional role for "D Y I G S" group. "P P - S - - - F L R" and "N R - Y - S 
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 Name: Q7PY38_ANOGA_276-510  Len:    260  Check: 5861  Weight: 1.00 
 Name: NICA_MOUSE_273-498    Len:    260  Check: 4890  Weight: 1.00 
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                      1                                                   50 
query_267-500         KFILVTCRLD TTTMFDGVGL GAMDSLMGFA VFTHVAYLL. ...KQLLPPQ 
Q7KS07_DROME_236-469  KFILVTCRLD TTTMFDGVGL GAMDSLMGFA VFTHVAYLL. ...KQLLPPQ 
Q7PY38_ANOGA_276-510  RIVLVSTRTD TTTMFDGVGL GAMDSVVPFA VLVAVAHFL. ...SQALP.. 
NICA_MOUSE_273-498    RVVVAATRLD SRSFFWNVAP GAESAVASFV TQLAAAEAL. ...HKA.PDV 
NICA_ARATH_251-460    PVVLTVASMD TASFFRDKSF GADSPISGLV ALLGAVDAL. ...SRV.DGI 
Q6Z743_ORYSA_248-457  PIIMVTASQD SASFFRDRSL GADSPISGLI ALLTAVDAL. ...SHL.HDI 
NICA_CAEEL_278-508    KYMMVTARMD SFGMIPEISV GEVSVLTSII SVLAAARSMG TQIEKWQKAS 
 
                      51                                                 100 
query_267-500         SKDLHNVLFV TFNGESYDYI GSQRFVYDME KLQFP....T ESTGTPPIAF 
Q7KS07_DROME_236-469  SKDLHNVLFV TFNGESYDYI GSQRFVYDME KLQFP....T ESTGTPPIAF 
Q7PY38_ANOGA_276-510  SND.RNVLFL FFNGESYDYI GSQRFVYDLQ TGAFP....S RGTQTKPISM 
NICA_MOUSE_273-498    TTLSRNVMFV FFQGETFDYI GSSRMVYDME NGKFP..... .......VRL 
NICA_ARATH_251-460    SNLKKQLVFL VLTGETWGYL GSRRFLHELD LHSDA..... ....VAGLSN 
Q6Z743_ORYSA_248-457  SNLKKQLVFA VFNGEAWGYL GSRKFLQELD QGADS..... ....VNGISS 
NICA_CAEEL_278-508    NTSNRNVFFA FFNGESLDYI GSGAAAYQME NGKFPQMIRS DRTHIHPIRP 
 
                      101                                                150 
query_267-500         DNIDFMLDIG TLDDISN... ..IKLH.... ALNGTTLAQQ ILERLNNYAK 
Q7KS07_DROME_236-469  DNIDFMLDIG TLDDISN... ..IKLH.... ALNGTTLAQQ ILERLNNYAK 
Q7PY38_ANOGA_276-510  DNIELMIDLG ALDNLTD... ....LHVY.. HAAPQPMATK VAELLRKINQ 
NICA_MOUSE_273-498    ENIDSFVELG QVALRTSLD. ..LWMHTDPM SQKNESVKNQ VEDLLATLEK 
NICA_ARATH_251-460    TSIETVLEIG SVGKGLSGGI NTFFAH.... KTRVSSVTNM TLDALKIAQD 
Q6Z743_ORYSA_248-457  LLIDQVLEIG SVGKAISQGY PLFYAH.... AAGNSSISMK MVDALQSASE 
NICA_CAEEL_278-508    NELDYILEVQ QIGVAKGRK. ..YYVHVD.. GERYQQNKTQ TDRVIDRIER 
 
                      151                                                200 
query_267-500         SPRYGFNLNI .QSEMSAHLP PTSAQSFLRR DPNFNALILN ARPT...NKY 
Q7KS07_DROME_236-469  SPRYGFNLNI .QSEMSAHLP PTSAQSFLRR DPNFNALILN ARPT...NKY 
Q7PY38_ANOGA_276-510  QFGFGIQAGQ PVMTTN..LP PVSAQSFLRE NITFPAVIVA SRPA...NRF 
NICA_MOUSE_273-498    SGAGVPEVVL RRLAQSQALP PSSLQRFLRA R.NISGVVLA DHSGSFHNRY 
NICA_ARATH_251-460    SLASKNIKIL SADTANPGIP PSSLMAFMRK NPQTSAVVLE DFDTNFVNKF 
Q6Z743_ORYSA_248-457  SLGSDNVKVK PAASSNPGVP PSSLMSFLGK NSSTPGLVLE DFDSQFSNRF 
NICA_CAEEL_278-508    GLRSHAFDLE KPSGSGDRVP PASWHSFAKA DAHVQSVLLA PYGKEYEYQR 
 
                      201                                                250 
query_267-500         YHSTYDDADN VDFTYANTSK ..DFTQLTEV N..DFKSLN. PDSLQMKVRN 
Q7KS07_DROME_236-469  YHSIYDDADN VDFTYANTSK ..DFTQLTEV N..DFKSLN. PDSLQMKVRN 
Q7PY38_ANOGA_276-510  YHSIYDDQEN LHYRYGNHSR KYDFTQLEDL DLGDRSDLYG KDSIQMRIRN 
NICA_MOUSE_273-498    YQSIYDTAEN INVTYPEWQS .......... ...PEEDLNF VTDTAKALAN 
NICA_ARATH_251-460    YHSHLDDLSN INS....... .......... .......... .....SSVVA 
Q6Z743_ORYSA_248-457  YHSTLDGPAN VNS....... .......... .......... .....SSIAA 
NICA_CAEEL_278-508    VNSILDKNE. .......... .......... ...WTEDERE KAIQEIEAVS 
 
                      251    
query_267-500         VSSIVAMALY 
Q7KS07_DROME_236-469  VSSIVAMALY 
Q7PY38_ANOGA_276-510  ASSLIGMSIY 
NICA_MOUSE_273-498    VATVLARALY 
NICA_ARATH_251-460    AASVVARTLY 
Q6Z743_ORYSA_248-457  AAALIARSLY 
NICA_CAEEL_278-508    TAILAAAADY 
 
Table 4. Sequence alignment between Nicastrin [Drosophila melanogaster] and the other 
six sets of Nicastrin variation. DYIGS is reported from our measure as confirmed by the 
γ-secretase review paper. Some other similar motif patterns are also reported, which are 
marked in red above. "F - - F - G E - - D Y I G S" is speculated as a motif pattern, which 
 35
might play an important functional role for "D Y I G S" group. "P P - S - - S F L R" and 
"N - - Y H S - - D - - - N" are other possible motif patterns from Nicastrin [Drosophila 
melanogaster]. 
 
Similar speculation can also be reached following the protocols. The analysis on 





Figure 8. Speculative Motif sites of Presenilin-1 [Homo Sapiens]. 
 
 
The motif pattern identification will be achieved following an automated protocol 
specialized to process γ-secretase. Some unprocessed multiple sequence alignment data 
are indicated for Presenilin-1. It's straightforward to see that the sliding window method 
can help obtain the motif patterns for γ-secretase by measure the short-range repetitious 
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                  1                                                   50 
query_67-455      DEELTLKYGA KHVIMLFVPV TLCMVVVVAT IKSVSFYTRK DG.QLIYTPF 
PSN_CAEEL_38-435  VEEAELKYGA SHVIHLFVPV SLCMALVVFT MNTITFYSQN NGRHLLYTPF 
PSN2_RAT_76-439   EEELTLKYGA KHVIMLFVPV TLCMIVVVAT IKSVRFYTEK NG.QLIYTPF 
PSN1_RAT_70-459   DEELTLKYGA KHVIMLFVPV TLCMVVVVAT IKSVSFYTRK DG.QLIYTPF 
PSN_DROME_92-532  EEEQGLKYGA QHVIKLFVPV SLCMLVVVAT INSISFYNST DV.YLLYTPF 
HOP1_CAEEL_1-349  MPRTKRVYSG KTITGVLYPV AICMLFVAIN VKLSQPEQQE QS.KVVYGLF 
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SPE4_CAEEL_5-465  RSISSELVRS SQLRWTLFSV IANMSLTLSI WIGVYNMEVN SELSKTYFLD 
 
                  51                                                 100 
query_67-455      TEDTETVGQR ALHSILNAAI MISVIVVMTI LLVVLYKYRC YKVIHAWLII 
PSN_CAEEL_38-435  VRETDSIVEK GLMSLGNALV MLCVVVLMTV LLIVFYKYKF YKLIHGWLIV 
PSN2_RAT_76-439   TEDTPSVGQR LLNSVLNTLI MISVIVVMTI FLVVLYKYRC YKFIHGWLIM 
PSN1_RAT_70-459   TEDTETVGQR ALHSILNAAI MISVIVVMTI LLVVLYKYRC YKVIHAWLIV 
PSN_DROME_92-532  HEQSPEPSVK FWSALANSLI LMSVVVVMTF LLIVLYKKRC YRIIHGWLIL 
HOP1_CAEEL_1-349  HS......YD TADSGTITLY LIGFLILTTS LGVFCYQMKF YKAIKVYVLA 
SPE4_CAEEL_5-465  PSFEQTTGNL LLDGFINGVG TILVLGCVSF IMLAFVLFDF RRIVKAWLTL 
 
                  101                                                150 
query_67-455      SSLLLLFFFS FIYLGEVFKT YN.......V AVDYITVALL IWNFGVVGMI 
PSN_CAEEL_38-435  SSFLLLFLFT TIYVQEVLKS FD.......V SPSALLVLFG LGNYGVLGMM 
PSN2_RAT_76-439   SSLMLLFLFT YIYLGEVFKT YN.......V AMDYPTLFLA VWNFGAVGMV 
PSN1_RAT_70-459   SSLLLLFFFS FIYLGEVFKT YN.......V AVDYITVALL IWNFGVVGMI 
PSN_DROME_92-532  SSFMLLFIFT YLYLEELLRA YN.......I PMDYPTALLI MWNFGVVGMM 
HOP1_CAEEL_1-349  NSIGILLVYS VFHFQRIAEA QS.......I PVSVPTFFFL ILQFGGLGIT 
SPE4_CAEEL_5-465  SCLLILFGVS AQTLHDMFSQ VFDQDDNNQY YMTIVLIVVP TVVYGFGGIY 
 
                  151                                                200 
query_67-455      SIHWKGPLRL QQAYLIMISA LMALVFIKYL PEWTAWLILA VISVYDLVAV 
PSN_CAEEL_38-435  CIHWKGPLRL QQFYLITMSA LMALVFIKYL PEWTVWFVLF VISVWDLVAV 
PSN2_RAT_76-439   CIHWKGPLVL QQAYLIVISA LMALVFIKYL PEWSAWVILG AISVYDLVAV 
PSN1_RAT_70-459   AIHWKGPLRL QQAYLIMISA LMALVFIKYL PEWTAWLILA VISVYDLVAV 
PSN_DROME_92-532  SIHWQGPLRL QQGYLIFVAA LMALVFIKYL PEWTAWAVLA AISIWDLIAV 
HOP1_CAEEL_1-349  CLHWKSHRRL HQFYLIMLAG LTAIFILNIL PDWTVWMALT AISFWDIVAV 
SPE4_CAEEL_5-465  AFFSNSSLIL HQIFVVTNCS LISVFYLRVF PSKTTWFVLW IVLFWDLFAV 
 
                  201                                                250 
query_67-455      LCPKGPLRML VETAQERNET LFPALIYSST MVWLVNM... ...AEGDPEA 
PSN_CAEEL_38-435  LTPKGPLRYL VETAQERNEP IFPALIYSSG VIYPYVLVTA VEN..TTDPR 
PSN2_RAT_76-439   LCPKGPLRML VETAQERNEP IFPALIYSSA .MVWTVG... .....MAK.. 
PSN1_RAT_70-459   LCPKGPLRML VETAQERNET LFPALIYSST MVWLVNM... ...AEGDPEA 
PSN_DROME_92-532  LSPRGPLRIL VETAQERNEQ IFPALIYSST VVYALVNTVT PQQSQATASS 
HOP1_CAEEL_1-349  LTPCGPLKML VETANRRGDD KFPAILYNSS SYVNEVD... ......SP.. 
SPE4_CAEEL_5-465  LAPMGPLKKV QEKASDYSKC VLNLIMFSAN EKRLTAGSNQ EETNEGEEST 
 
                  251                                                300 
query_67-455      QRRVSK.N.. .......... .......... .........S KYNAE..... 
PSN_CAEEL_38-435  EPTSSDSN.. .......... .........T STAFPGEASC SSETP..... 
PSN2_RAT_76-439   ....LD.... .......... .......... ........PS SQGAL..... 
PSN1_RAT_70-459   QRRVPK.N.. .......... .......... .........P KYSTQ..... 
PSN_DROME_92-532  SPSSSNST.. .TTTRATQ.. .........N SLASPEAAAA SGQRT..... 
HOP1_CAEEL_1-349  ..DTTR.... .......... .......... .......... .......... 
SPE4_CAEEL_5-465  IRRTVKQTIE YYTKREAQDD EFYQKIRQRR AAINPDSVPT EHSPLVEAEP 
 
                  301                                                350 
query_67-455      .STERES.QD TVAENDDGGF SEEWE..... A......... ......QRDS 
PSN_CAEEL_38-435  ...KRPKVKR IPQKVQIESN TTAST..... T......... ......QNSG 
PSN2_RAT_76-439   ...QLPY... DPEMEEDSYD SFGEP..... S......... .......... 
PSN1_RAT_70-459   .GTEREETQD TGTGSDDGGF SEEWE..... A......... ......QRDS 
PSN_DROME_92-532  .....GN.SH PRQNQRDDGS VLATEGMPLV TFKSNLRGNA EAAGFTQEWS 
HOP1_CAEEL_1-349  .....SN.ST PLTEFNNSSS SRLLE..... S......... ........DS 
SPE4_CAEEL_5-465  SPIELKEKNS TEELSDDESD TSETS..... SGSSNLSSSD SSTTVSTSDI 
 
                  351                                                400 
query_67-455      HLGPHRsTPE SRAAVQELSS ....SILAG. ...ED..... .....PEERG 
PSN_CAEEL_38-435  VRVE....RE LAAERPTVQD ....ANFHR. ..HEE..... ......EERG 
PSN2_RAT_76-439   ..YP....EA FEAPQPGYP. .........G EEPEE..... .....EEERG 
PSN1_RAT_70-459   HLGPHRsTPE SRAAVQELSG ....SILTS. ...ED..... .....PEERG 
PSN_DROME_92-532  ANLS....ER VARRQIEVQS tqsgNAQRSN EYRTVTAPDQ NHPDGQEERG 
HOP1_CAEEL_1-349  LLRP....PV IPRQIREVR. .......... .......... .....EVEGT 
SPE4_CAEEL_5-465  STAE....EC DQKEWDDLVS ....NSLPNN DKRPATAADA L....NDGEV 
 
                  401                                                450 
query_67-455      VKLGLGDFIF YSVLVGKASA TASGDWNTTI ACFVAILIGL CLTLLLLAIF 
PSN_CAEEL_38-435  VKLGLGDFIF YSVLLGKASS Y..FDWNTTI ACYVAILIGL CFTLVLLAVF 
PSN2_RAT_76-439   VKLGLGDFIF YSVLVGKAAA TGNGDWSTTL ACFIAILIGL CLTLLLLAVF 
PSN1_RAT_70-459   VKLGLGDFIF YSVLVGKASA TASGDWNTTI ACFVAILIGL CLTLLLLAIF 
PSN_DROME_92-532  IKLGLGDFIF YSVLVGKASS Y..GDWTTTI ACFVAILIGL CLTLLLLAIW 
 37
HOP1_CAEEL_1-349  IRLGMGDFVF YSLMLGNTVQ T..CPLPTVV ACFVSNLVGL TITLPIVTLS 
SPE4_CAEEL_5-465  LRLGFGDFVF YSLLIGQAAA S..GCPFAVI SAALGILFGL VVTLTVFSTE 
 
                  451                          480 
query_67-455      KKALPALPIS ITFGLVFYFA TDYLVQPFMD 
PSN_CAEEL_38-435  KRALPALPIS IFSGLIFYFC TRWIITPFVT 
PSN2_RAT_76-439   KKALPALPIS ITFGLIFYFS TDNLVRPFMD 
PSN1_RAT_70-459   KKALPALPIS ITFGLIFYFA TDYLVQPFMD 
PSN_DROME_92-532  RKALPALPIS ITFGLIFCFA TSAVVKPFME 
HOP1_CAEEL_1-349  QTALPALPFP LAIAAIFYFS SHIALTPFTD 
SPE4_CAEEL_5-465  ESTTPALPLP VICGTFCYFS SMFFWEQLYG 
 





 squid.msf  MSF: 480  Type: P  January 28, 2007 22:29  Check: 956  .. 
 
 Name: query_43-431      Len:    480  Check: 8409  Weight: 1.00 
 Name: PSN_CAEEL_38-435  Len:    480  Check: 8470  Weight: 1.00 
 Name: PSN2_RAT_76-439   Len:    480  Check: 7001  Weight: 1.00 
 Name: PSN1_RAT_70-459   Len:    480  Check:  744  Weight: 1.00 
 Name: PSN_DROME_92-532  Len:    480  Check: 1070  Weight: 1.00 
 Name: HOP1_CAEEL_1-349  Len:    480  Check: 6457  Weight: 1.00 




                  1                                                   50 
query_43-431      DEELTLKYGA KHVIMLFIPV TLCMVVVVAT IKSVSFYTQK DGQQLIYTPF 
PSN_CAEEL_38-435  VEEAELKYGA SHVIHLFVPV SLCMALVVFT MNTITFYSQN NGRHLLYTPF 
PSN2_RAT_76-439   EEELTLKYGA KHVIMLFVPV TLCMIVVVAT IKSVRFYTEK NG.QLIYTPF 
PSN1_RAT_70-459   DEELTLKYGA KHVIMLFVPV TLCMVVVVAT IKSVSFYTRK DG.QLIYTPF 
PSN_DROME_92-532  EEEQGLKYGA QHVIKLFVPV SLCMLVVVAT INSISFYNST DV.YLLYTPF 
HOP1_CAEEL_1-349  MPRTKRVYSG KTITGVLYPV AICMLFVAIN VKLSQPEQQE QS.KVVYGLF 
SPE4_CAEEL_5-465  RSISSELVRS SQLRWTLFSV IANMSLTLSI WIGVYNMEVN SELSKTYFLD 
 
                  51                                                 100 
query_43-431      REDTETVGQR ALHSMLNAII MISVIVVMTL VLVVLYKYRC YKVIQAWLFF 
PSN_CAEEL_38-435  VRETDSIVEK GLMSLGNALV MLCVVVLMTV LLIVFYKYKF YKLIHGWLIV 
PSN2_RAT_76-439   TEDTPSVGQR LLNSVLNTLI MISVIVVMTI FLVVLYKYRC YKFIHGWLIM 
PSN1_RAT_70-459   TEDTETVGQR ALHSILNAAI MISVIVVMTI LLVVLYKYRC YKVIHAWLIV 
PSN_DROME_92-532  HEQSPEPSVK FWSALANSLI LMSVVVVMTF LLIVLYKKRC YRIIHGWLIL 
HOP1_CAEEL_1-349  HS......YD TADSGTITLY LIGFLILTTS LGVFCYQMKF YKAIKVYVLA 
SPE4_CAEEL_5-465  PSFEQTTGNL LLDGFINGVG TILVLGCVSF IMLAFVLFDF RRIVKAWLTL 
 
                  101                                                150 
query_43-431      SNLLLLFFFS LIYLGEVFKT YN.......V AMDYFTLALI IWNFGVVGMI 
PSN_CAEEL_38-435  SSFLLLFLFT TIYVQEVLKS FD.......V SPSALLVLFG LGNYGVLGMM 
PSN2_RAT_76-439   SSLMLLFLFT YIYLGEVFKT YN.......V AMDYPTLFLA VWNFGAVGMV 
PSN1_RAT_70-459   SSLLLLFFFS FIYLGEVFKT YN.......V AVDYITVALL IWNFGVVGMI 
PSN_DROME_92-532  SSFMLLFIFT YLYLEELLRA YN.......I PMDYPTALLI MWNFGVVGMM 
HOP1_CAEEL_1-349  NSIGILLVYS VFHFQRIAEA QS.......I PVSVPTFFFL ILQFGGLGIT 
SPE4_CAEEL_5-465  SCLLILFGVS AQTLHDMFSQ VFDQDDNNQY YMTIVLIVVP TVVYGFGGIY 
 
                  151                                                200 
query_43-431      CIHWKGPLRL QQAYLIMISA LMALVFIKYL PEWTAWLILA AISVYDLLAV 
PSN_CAEEL_38-435  CIHWKGPLRL QQFYLITMSA LMALVFIKYL PEWTVWFVLF VISVWDLVAV 
PSN2_RAT_76-439   CIHWKGPLVL QQAYLIVISA LMALVFIKYL PEWSAWVILG AISVYDLVAV 
PSN1_RAT_70-459   AIHWKGPLRL QQAYLIMISA LMALVFIKYL PEWTAWLILA VISVYDLVAV 
PSN_DROME_92-532  SIHWQGPLRL QQGYLIFVAA LMALVFIKYL PEWTAWAVLA AISIWDLIAV 
HOP1_CAEEL_1-349  CLHWKSHRRL HQFYLIMLAG LTAIFILNIL PDWTVWMALT AISFWDIVAV 
SPE4_CAEEL_5-465  AFFSNSSLIL HQIFVVTNCS LISVFYLRVF PSKTTWFVLW IVLFWDLFAV 
 
                  201                                                250 
query_43-431      LCPKGPLRIL VETAQERNEA IFPALIYSST MVWLFNM... ADSAETRN.. 
PSN_CAEEL_38-435  LTPKGPLRYL VETAQERNEP IFPALIYSSG VIYPYVLVTA VEN..TTDPR 
 38
PSN2_RAT_76-439   LCPKGPLRML VETAQERNEP IFPALIYSSA .MVWTVG... .....MAK.. 
PSN1_RAT_70-459   LCPKGPLRML VETAQERNET LFPALIYSST MVWLVNM... ...AEGDPEA 
PSN_DROME_92-532  LSPRGPLRIL VETAQERNEQ IFPALIYSST VVYALVNTVT PQQSQATASS 
HOP1_CAEEL_1-349  LTPCGPLKML VETANRRGDD KFPAILYNSS SYVNEVD... ......SP.. 
SPE4_CAEEL_5-465  LAPMGPLKKV QEKASDYSKC VLNLIMFSAN EKRLTAGSNQ EETNEGEEST 
 
                  251                                                300 
query_43-431      ..NSSH.... .......... .......... ........PV PQQEN..... 
PSN_CAEEL_38-435  EPTSSDSN.. .......... .........T STAFPGEASC SSETP..... 
PSN2_RAT_76-439   ....LD.... .......... .......... ........PS SQGAL..... 
PSN1_RAT_70-459   QRRVPK.N.. .......... .......... .........P KYSTQ..... 
PSN_DROME_92-532  SPSSSNST.. .TTTRATQ.. .........N SLASPEAAAA SGQRT..... 
HOP1_CAEEL_1-349  ..DTTR.... .......... .......... .......... .......... 
SPE4_CAEEL_5-465  IRRTVKQTIE YYTKREAQDD EFYQKIRQRR AAINPDSVPT EHSPLVEAEP 
 
                  301                                                350 
query_43-431      ...QVAM.AP TAQPEDDGGF TPAWV..... D......... ......HQQH 
PSN_CAEEL_38-435  ...KRPKVKR IPQKVQIESN TTAST..... T......... ......QNSG 
PSN2_RAT_76-439   ...QLPY... DPEMEEDSYD SFGEP..... S......... .......... 
PSN1_RAT_70-459   .GTEREETQD TGTGSDDGGF SEEWE..... A......... ......QRDS 
PSN_DROME_92-532  .....GN.SH PRQNQRDDGS VLATEGMPLV TFKSNLRGNA EAAGFTQEWS 
HOP1_CAEEL_1-349  .....SN.ST PLTEFNNSSS SRLLE..... S......... ........DS 
SPE4_CAEEL_5-465  SPIELKEKNS TEELSDDESD TSETS..... SGSSNLSSSD SSTTVSTSDI 
 
                  351                                                400 
query_43-431      QLGPMQsTEE SRRQIQEMPS ....ARPPP. ...PA..... ...DDDEERG 
PSN_CAEEL_38-435  VRVE....RE LAAERPTVQD ....ANFHR. ..HEE..... ......EERG 
PSN2_RAT_76-439   ..YP....EA FEAPQPGYP. .........G EEPEE..... .....EEERG 
PSN1_RAT_70-459   HLGPHRsTPE SRAAVQELSG ....SILTS. ...ED..... .....PEERG 
PSN_DROME_92-532  ANLS....ER VARRQIEVQS tqsgNAQRSN EYRTVTAPDQ NHPDGQEERG 
HOP1_CAEEL_1-349  LLRP....PV IPRQIREVR. .......... .......... .....EVEGT 
SPE4_CAEEL_5-465  STAE....EC DQKEWDDLVS ....NSLPNN DKRPATAADA L....NDGEV 
 
                  401                                                450 
query_43-431      VKLGLGDFIF YSMLVGKASA TASGDWNTTL ACFVAILIGL CLTLLLLAIF 
PSN_CAEEL_38-435  VKLGLGDFIF YSVLLGKASS Y..FDWNTTI ACYVAILIGL CFTLVLLAVF 
PSN2_RAT_76-439   VKLGLGDFIF YSVLVGKAAA TGNGDWSTTL ACFIAILIGL CLTLLLLAVF 
PSN1_RAT_70-459   VKLGLGDFIF YSVLVGKASA TASGDWNTTI ACFVAILIGL CLTLLLLAIF 
PSN_DROME_92-532  IKLGLGDFIF YSVLVGKASS Y..GDWTTTI ACFVAILIGL CLTLLLLAIW 
HOP1_CAEEL_1-349  IRLGMGDFVF YSLMLGNTVQ T..CPLPTVV ACFVSNLVGL TITLPIVTLS 
SPE4_CAEEL_5-465  LRLGFGDFVF YSLLIGQAAA S..GCPFAVI SAALGILFGL VVTLTVFSTE 
 
                  451                          480 
query_43-431      KKALPALPIS ITFGLVFYFA TDNLVRPFMD 
PSN_CAEEL_38-435  KRALPALPIS IFSGLIFYFC TRWIITPFVT 
PSN2_RAT_76-439   KKALPALPIS ITFGLIFYFS TDNLVRPFMD 
PSN1_RAT_70-459   KKALPALPIS ITFGLIFYFA TDYLVQPFMD 
PSN_DROME_92-532  RKALPALPIS ITFGLIFCFA TSAVVKPFME 
HOP1_CAEEL_1-349  QTALPALPFP LAIAAIFYFS SHIALTPFTD 
SPE4_CAEEL_5-465  ESTTPALPLP VICGTFCYFS SMFFWEQLYG 
 





 squid.msf  MSF: 480  Type: P  January 28, 2007 22:35  Check: 1932  .. 
 
 Name: query_71-459      Len:    480  Check: 9385  Weight: 1.00 
 Name: PSN_CAEEL_38-435  Len:    480  Check: 8470  Weight: 1.00 
 Name: PSN2_RAT_76-439   Len:    480  Check: 7001  Weight: 1.00 
 Name: PSN1_RAT_70-459   Len:    480  Check:  744  Weight: 1.00 
 Name: PSN_DROME_92-532  Len:    480  Check: 1070  Weight: 1.00 
 Name: HOP1_CAEEL_1-349  Len:    480  Check: 6457  Weight: 1.00 





                  1                                                   50 
query_71-459      DEELTLKYGA KHVIMLFVPV TLCMVVVVAT IKSVSFYTRK DG.QLIYTPF 
PSN_CAEEL_38-435  VEEAELKYGA SHVIHLFVPV SLCMALVVFT MNTITFYSQN NGRHLLYTPF 
PSN2_RAT_76-439   EEELTLKYGA KHVIMLFVPV TLCMIVVVAT IKSVRFYTEK NG.QLIYTPF 
PSN1_RAT_70-459   DEELTLKYGA KHVIMLFVPV TLCMVVVVAT IKSVSFYTRK DG.QLIYTPF 
PSN_DROME_92-532  EEEQGLKYGA QHVIKLFVPV SLCMLVVVAT INSISFYNST DV.YLLYTPF 
HOP1_CAEEL_1-349  MPRTKRVYSG KTITGVLYPV AICMLFVAIN VKLSQPEQQE QS.KVVYGLF 
SPE4_CAEEL_5-465  RSISSELVRS SQLRWTLFSV IANMSLTLSI WIGVYNMEVN SELSKTYFLD 
 
                  51                                                 100 
query_71-459      TEDTETVGQR ALHSILNAAI MISVIVIMTI LLVVLYKYRC YKVIHAWLII 
PSN_CAEEL_38-435  VRETDSIVEK GLMSLGNALV MLCVVVLMTV LLIVFYKYKF YKLIHGWLIV 
PSN2_RAT_76-439   TEDTPSVGQR LLNSVLNTLI MISVIVVMTI FLVVLYKYRC YKFIHGWLIM 
PSN1_RAT_70-459   TEDTETVGQR ALHSILNAAI MISVIVVMTI LLVVLYKYRC YKVIHAWLIV 
PSN_DROME_92-532  HEQSPEPSVK FWSALANSLI LMSVVVVMTF LLIVLYKKRC YRIIHGWLIL 
HOP1_CAEEL_1-349  HS......YD TADSGTITLY LIGFLILTTS LGVFCYQMKF YKAIKVYVLA 
SPE4_CAEEL_5-465  PSFEQTTGNL LLDGFINGVG TILVLGCVSF IMLAFVLFDF RRIVKAWLTL 
 
                  101                                                150 
query_71-459      SSLLLLFFFS FIYLGEVFKT YN.......V AVDYVTVALL IWNFGVVGMI 
PSN_CAEEL_38-435  SSFLLLFLFT TIYVQEVLKS FD.......V SPSALLVLFG LGNYGVLGMM 
PSN2_RAT_76-439   SSLMLLFLFT YIYLGEVFKT YN.......V AMDYPTLFLA VWNFGAVGMV 
PSN1_RAT_70-459   SSLLLLFFFS FIYLGEVFKT YN.......V AVDYITVALL IWNFGVVGMI 
PSN_DROME_92-532  SSFMLLFIFT YLYLEELLRA YN.......I PMDYPTALLI MWNFGVVGMM 
HOP1_CAEEL_1-349  NSIGILLVYS VFHFQRIAEA QS.......I PVSVPTFFFL ILQFGGLGIT 
SPE4_CAEEL_5-465  SCLLILFGVS AQTLHDMFSQ VFDQDDNNQY YMTIVLIVVP TVVYGFGGIY 
 
                  151                                                200 
query_71-459      AIHWKGPLRL QQAYLIMISA LMALVFIKYL PEWTAWLILA VISVYDLVAV 
PSN_CAEEL_38-435  CIHWKGPLRL QQFYLITMSA LMALVFIKYL PEWTVWFVLF VISVWDLVAV 
PSN2_RAT_76-439   CIHWKGPLVL QQAYLIVISA LMALVFIKYL PEWSAWVILG AISVYDLVAV 
PSN1_RAT_70-459   AIHWKGPLRL QQAYLIMISA LMALVFIKYL PEWTAWLILA VISVYDLVAV 
PSN_DROME_92-532  SIHWQGPLRL QQGYLIFVAA LMALVFIKYL PEWTAWAVLA AISIWDLIAV 
HOP1_CAEEL_1-349  CLHWKSHRRL HQFYLIMLAG LTAIFILNIL PDWTVWMALT AISFWDIVAV 
SPE4_CAEEL_5-465  AFFSNSSLIL HQIFVVTNCS LISVFYLRVF PSKTTWFVLW IVLFWDLFAV 
 
                  201                                                250 
query_71-459      LCPKGPLRML VETAQERNET LFPALIYSST MVWLVNM... ...AEGDPEA 
PSN_CAEEL_38-435  LTPKGPLRYL VETAQERNEP IFPALIYSSG VIYPYVLVTA VEN..TTDPR 
PSN2_RAT_76-439   LCPKGPLRML VETAQERNEP IFPALIYSSA .MVWTVG... .....MAK.. 
PSN1_RAT_70-459   LCPKGPLRML VETAQERNET LFPALIYSST MVWLVNM... ...AEGDPEA 
PSN_DROME_92-532  LSPRGPLRIL VETAQERNEQ IFPALIYSST VVYALVNTVT PQQSQATASS 
HOP1_CAEEL_1-349  LTPCGPLKML VETANRRGDD KFPAILYNSS SYVNEVD... ......SP.. 
SPE4_CAEEL_5-465  LAPMGPLKKV QEKASDYSKC VLNLIMFSAN EKRLTAGSNQ EETNEGEEST 
 
                  251                                                300 
query_71-459      QRRVPK.N.. .......... .......... .........P KYNTQ..... 
PSN_CAEEL_38-435  EPTSSDSN.. .......... .........T STAFPGEASC SSETP..... 
PSN2_RAT_76-439   ....LD.... .......... .......... ........PS SQGAL..... 
PSN1_RAT_70-459   QRRVPK.N.. .......... .......... .........P KYSTQ..... 
PSN_DROME_92-532  SPSSSNST.. .TTTRATQ.. .........N SLASPEAAAA SGQRT..... 
HOP1_CAEEL_1-349  ..DTTR.... .......... .......... .......... .......... 
SPE4_CAEEL_5-465  IRRTVKQTIE YYTKREAQDD EFYQKIRQRR AAINPDSVPT EHSPLVEAEP 
 
                  301                                                350 
query_71-459      .RAERET.QD SGSGNDDGGF SEEWE..... A......... ......QRDS 
PSN_CAEEL_38-435  ...KRPKVKR IPQKVQIESN TTAST..... T......... ......QNSG 
PSN2_RAT_76-439   ...QLPY... DPEMEEDSYD SFGEP..... S......... .......... 
PSN1_RAT_70-459   .GTEREETQD TGTGSDDGGF SEEWE..... A......... ......QRDS 
PSN_DROME_92-532  .....GN.SH PRQNQRDDGS VLATEGMPLV TFKSNLRGNA EAAGFTQEWS 
HOP1_CAEEL_1-349  .....SN.ST PLTEFNNSSS SRLLE..... S......... ........DS 
SPE4_CAEEL_5-465  SPIELKEKNS TEELSDDESD TSETS..... SGSSNLSSSD SSTTVSTSDI 
 
                  351                                                400 
query_71-459      HLGPHRsTPE SRAAVQELSG ....SILTS. ...ED..... .....PEERG 
PSN_CAEEL_38-435  VRVE....RE LAAERPTVQD ....ANFHR. ..HEE..... ......EERG 
PSN2_RAT_76-439   ..YP....EA FEAPQPGYP. .........G EEPEE..... .....EEERG 
PSN1_RAT_70-459   HLGPHRsTPE SRAAVQELSG ....SILTS. ...ED..... .....PEERG 
PSN_DROME_92-532  ANLS....ER VARRQIEVQS tqsgNAQRSN EYRTVTAPDQ NHPDGQEERG 
HOP1_CAEEL_1-349  LLRP....PV IPRQIREVR. .......... .......... .....EVEGT 
SPE4_CAEEL_5-465  STAE....EC DQKEWDDLVS ....NSLPNN DKRPATAADA L....NDGEV 
 40
 
                  401                                                450 
query_71-459      VKLGLGDFIF YSVLVGKASA TASGDWNTTI ACFVAILIGL CLTLLLLAIF 
PSN_CAEEL_38-435  VKLGLGDFIF YSVLLGKASS Y..FDWNTTI ACYVAILIGL CFTLVLLAVF 
PSN2_RAT_76-439   VKLGLGDFIF YSVLVGKAAA TGNGDWSTTL ACFIAILIGL CLTLLLLAVF 
PSN1_RAT_70-459   VKLGLGDFIF YSVLVGKASA TASGDWNTTI ACFVAILIGL CLTLLLLAIF 
PSN_DROME_92-532  IKLGLGDFIF YSVLVGKASS Y..GDWTTTI ACFVAILIGL CLTLLLLAIW 
HOP1_CAEEL_1-349  IRLGMGDFVF YSLMLGNTVQ T..CPLPTVV ACFVSNLVGL TITLPIVTLS 
SPE4_CAEEL_5-465  LRLGFGDFVF YSLLIGQAAA S..GCPFAVI SAALGILFGL VVTLTVFSTE 
 
                  451                          480 
query_71-459      KKALPALPIS ITFGLVFYFA TDYLVQPFMD 
PSN_CAEEL_38-435  KRALPALPIS IFSGLIFYFC TRWIITPFVT 
PSN2_RAT_76-439   KKALPALPIS ITFGLIFYFS TDNLVRPFMD 
PSN1_RAT_70-459   KKALPALPIS ITFGLIFYFA TDYLVQPFMD 
PSN_DROME_92-532  RKALPALPIS ITFGLIFCFA TSAVVKPFME 
HOP1_CAEEL_1-349  QTALPALPFP LAIAAIFYFS SHIALTPFTD 
SPE4_CAEEL_5-465  ESTTPALPLP VICGTFCYFS SMFFWEQLYG 
 





 squid.msf  MSF: 480  Type: P  January 28, 2007 22:40  Check: 4201  .. 
 
 Name: query_65-453      Len:    480  Check: 1654  Weight: 1.00 
 Name: PSN_CAEEL_38-435  Len:    480  Check: 8470  Weight: 1.00 
 Name: PSN2_RAT_76-439   Len:    480  Check: 7001  Weight: 1.00 
 Name: PSN1_RAT_70-459   Len:    480  Check:  744  Weight: 1.00 
 Name: PSN_DROME_92-532  Len:    480  Check: 1070  Weight: 1.00 
 Name: HOP1_CAEEL_1-349  Len:    480  Check: 6457  Weight: 1.00 




                  1                                                   50 
query_65-453      DEELTLKYGA KHVIMLFVPV TLCMVVVVAT IKSVSFYTRY DG.QLIYTPF 
PSN_CAEEL_38-435  VEEAELKYGA SHVIHLFVPV SLCMALVVFT MNTITFYSQN NGRHLLYTPF 
PSN2_RAT_76-439   EEELTLKYGA KHVIMLFVPV TLCMIVVVAT IKSVRFYTEK NG.QLIYTPF 
PSN1_RAT_70-459   DEELTLKYGA KHVIMLFVPV TLCMVVVVAT IKSVSFYTRK DG.QLIYTPF 
PSN_DROME_92-532  EEEQGLKYGA QHVIKLFVPV SLCMLVVVAT INSISFYNST DV.YLLYTPF 
HOP1_CAEEL_1-349  MPRTKRVYSG KTITGVLYPV AICMLFVAIN VKLSQPEQQE QS.KVVYGLF 
SPE4_CAEEL_5-465  RSISSELVRS SQLRWTLFSV IANMSLTLSI WIGVYNMEVN SELSKTYFLD 
 
                  51                                                 100 
query_65-453      TEDTDSVGQR ALNSILNTAI MISVIIVMTI LLVVLYKYRC YKVIHGWLII 
PSN_CAEEL_38-435  VRETDSIVEK GLMSLGNALV MLCVVVLMTV LLIVFYKYKF YKLIHGWLIV 
PSN2_RAT_76-439   TEDTPSVGQR LLNSVLNTLI MISVIVVMTI FLVVLYKYRC YKFIHGWLIM 
PSN1_RAT_70-459   TEDTETVGQR ALHSILNAAI MISVIVVMTI LLVVLYKYRC YKVIHAWLIV 
PSN_DROME_92-532  HEQSPEPSVK FWSALANSLI LMSVVVVMTF LLIVLYKKRC YRIIHGWLIL 
HOP1_CAEEL_1-349  HS......YD TADSGTITLY LIGFLILTTS LGVFCYQMKF YKAIKVYVLA 
SPE4_CAEEL_5-465  PSFEQTTGNL LLDGFINGVG TILVLGCVSF IMLAFVLFDF RRIVKAWLTL 
 
                  101                                                150 
query_65-453      SSLLLLFFFS YIYLGEVFKT YN.......V AMDYITLALM IWNFGVVGMI 
PSN_CAEEL_38-435  SSFLLLFLFT TIYVQEVLKS FD.......V SPSALLVLFG LGNYGVLGMM 
PSN2_RAT_76-439   SSLMLLFLFT YIYLGEVFKT YN.......V AMDYPTLFLA VWNFGAVGMV 
PSN1_RAT_70-459   SSLLLLFFFS FIYLGEVFKT YN.......V AVDYITVALL IWNFGVVGMI 
PSN_DROME_92-532  SSFMLLFIFT YLYLEELLRA YN.......I PMDYPTALLI MWNFGVVGMM 
HOP1_CAEEL_1-349  NSIGILLVYS VFHFQRIAEA QS.......I PVSVPTFFFL ILQFGGLGIT 
SPE4_CAEEL_5-465  SCLLILFGVS AQTLHDMFSQ VFDQDDNNQY YMTIVLIVVP TVVYGFGGIY 
 
                  151                                                200 
query_65-453      CIHWKGPLLL QQAYLIMISA LMALVFIKYL PEWTTWLILA VISVYDLIAV 
PSN_CAEEL_38-435  CIHWKGPLRL QQFYLITMSA LMALVFIKYL PEWTVWFVLF VISVWDLVAV 
PSN2_RAT_76-439   CIHWKGPLVL QQAYLIVISA LMALVFIKYL PEWSAWVILG AISVYDLVAV 
PSN1_RAT_70-459   AIHWKGPLRL QQAYLIMISA LMALVFIKYL PEWTAWLILA VISVYDLVAV 
 41
PSN_DROME_92-532  SIHWQGPLRL QQGYLIFVAA LMALVFIKYL PEWTAWAVLA AISIWDLIAV 
HOP1_CAEEL_1-349  CLHWKSHRRL HQFYLIMLAG LTAIFILNIL PDWTVWMALT AISFWDIVAV 
SPE4_CAEEL_5-465  AFFSNSSLIL HQIFVVTNCS LISVFYLRVF PSKTTWFVLW IVLFWDLFAV 
 
                  201                                                250 
query_65-453      LSPKGPLRML VETAQERNET LFPALIYSST MIWLVKM... ...ADGDPGF 
PSN_CAEEL_38-435  LTPKGPLRYL VETAQERNEP IFPALIYSSG VIYPYVLVTA VEN..TTDPR 
PSN2_RAT_76-439   LCPKGPLRML VETAQERNEP IFPALIYSSA .MVWTVG... .....MAK.. 
PSN1_RAT_70-459   LCPKGPLRML VETAQERNET LFPALIYSST MVWLVNM... ...AEGDPEA 
PSN_DROME_92-532  LSPRGPLRIL VETAQERNEQ IFPALIYSST VVYALVNTVT PQQSQATASS 
HOP1_CAEEL_1-349  LTPCGPLKML VETANRRGDD KFPAILYNSS SYVNEVD... ......SP.. 
SPE4_CAEEL_5-465  LAPMGPLKKV QEKASDYSKC VLNLIMFSAN EKRLTAGSNQ EETNEGEEST 
 
                  251                                                300 
query_65-453      KQSASKKT.. .......... .......... .......... .YNAQ..... 
PSN_CAEEL_38-435  EPTSSDSN.. .......... .........T STAFPGEASC SSETP..... 
PSN2_RAT_76-439   ....LD.... .......... .......... ........PS SQGAL..... 
PSN1_RAT_70-459   QRRVPK.N.. .......... .......... .........P KYSTQ..... 
PSN_DROME_92-532  SPSSSNST.. .TTTRATQ.. .........N SLASPEAAAA SGQRT..... 
HOP1_CAEEL_1-349  ..DTTR.... .......... .......... .......... .......... 
SPE4_CAEEL_5-465  IRRTVKQTIE YYTKREAQDD EFYQKIRQRR AAINPDSVPT EHSPLVEAEP 
 
                  301                                                350 
query_65-453      APVAQPR.SD SAASDDNGGF DTAWE..... E......... ......QRNE 
PSN_CAEEL_38-435  ...KRPKVKR IPQKVQIESN TTAST..... T......... ......QNSG 
PSN2_RAT_76-439   ...QLPY... DPEMEEDSYD SFGEP..... S......... .......... 
PSN1_RAT_70-459   .GTEREETQD TGTGSDDGGF SEEWE..... A......... ......QRDS 
PSN_DROME_92-532  .....GN.SH PRQNQRDDGS VLATEGMPLV TFKSNLRGNA EAAGFTQEWS 
HOP1_CAEEL_1-349  .....SN.ST PLTEFNNSSS SRLLE..... S......... ........DS 
SPE4_CAEEL_5-465  SPIELKEKNS TEELSDDESD TSETS..... SGSSNLSSSD SSTTVSTSDI 
 
                  351                                                400 
query_65-453      QIGQINsTPE SRAAVQALPS ....NNPPS. ...ED..... .....PEERG 
PSN_CAEEL_38-435  VRVE....RE LAAERPTVQD ....ANFHR. ..HEE..... ......EERG 
PSN2_RAT_76-439   ..YP....EA FEAPQPGYP. .........G EEPEE..... .....EEERG 
PSN1_RAT_70-459   HLGPHRsTPE SRAAVQELSG ....SILTS. ...ED..... .....PEERG 
PSN_DROME_92-532  ANLS....ER VARRQIEVQS tqsgNAQRSN EYRTVTAPDQ NHPDGQEERG 
HOP1_CAEEL_1-349  LLRP....PV IPRQIREVR. .......... .......... .....EVEGT 
SPE4_CAEEL_5-465  STAE....EC DQKEWDDLVS ....NSLPNN DKRPATAADA L....NDGEV 
 
                  401                                                450 
query_65-453      VKLGLGDFIF YSVLVGKASA TASGDWNTTL ACFVAILIGL CLTLLLLAIF 
PSN_CAEEL_38-435  VKLGLGDFIF YSVLLGKASS Y..FDWNTTI ACYVAILIGL CFTLVLLAVF 
PSN2_RAT_76-439   VKLGLGDFIF YSVLVGKAAA TGNGDWSTTL ACFIAILIGL CLTLLLLAVF 
PSN1_RAT_70-459   VKLGLGDFIF YSVLVGKASA TASGDWNTTI ACFVAILIGL CLTLLLLAIF 
PSN_DROME_92-532  IKLGLGDFIF YSVLVGKASS Y..GDWTTTI ACFVAILIGL CLTLLLLAIW 
HOP1_CAEEL_1-349  IRLGMGDFVF YSLMLGNTVQ T..CPLPTVV ACFVSNLVGL TITLPIVTLS 
SPE4_CAEEL_5-465  LRLGFGDFVF YSLLIGQAAA S..GCPFAVI SAALGILFGL VVTLTVFSTE 
 
                  451                          480 
query_65-453      KKALPALPIS ITFGLVFYFA TDYLVQPFMD 
PSN_CAEEL_38-435  KRALPALPIS IFSGLIFYFC TRWIITPFVT 
PSN2_RAT_76-439   KKALPALPIS ITFGLIFYFS TDNLVRPFMD 
PSN1_RAT_70-459   KKALPALPIS ITFGLIFYFA TDYLVQPFMD 
PSN_DROME_92-532  RKALPALPIS ITFGLIFCFA TSAVVKPFME 
HOP1_CAEEL_1-349  QTALPALPFP LAIAAIFYFS SHIALTPFTD 
SPE4_CAEEL_5-465  ESTTPALPLP VICGTFCYFS SMFFWEQLYG 
 









5. Discussion and Conclusion 
 
γ-Secretase is an enzymatic complex which is critical to amyloid formation and other 
important pathophysiological processes. Non-specific γ-secretase inhibitors are not ideal 
for the intervention of familial Alzheimer’s disease. The four essential inhibitors include 
Presenilin (PS1 or PS-2), APH-1, Pen-2, nicastrin (Nct). Also γ-secretase cleaves a 
variety of substrates (over 30). But different sites are cleaved even in a single substrate 
and no consensus sequence for cleavage by γ-secretase is identified. We predict 
consensus structural sequence in components of γ-secretase and its substrates should exist 
during γ-secretase regulation and specific γ-secretase inhibitor based on such consensus 
may act as a therapeutic intervention for familial Alzheimer’s disease. We accomplish 
Stage I and successfully verify Stage II of our initial proposal. We find the candidates by 
the comparative methods of bioinformatics. By using the resources of motif identification 
and domain prediction databases and tools, selecting software to apply sequence analysis, 
modeling and simulation, and pattern recognition of γ-secretase regulation, we find out 
the candidates of consensus sequences. We collaborate to use the traditional biological 
methods and verify the critical role of the candidates including the protein purification, 
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